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TUNING OF NEURONAL EXCITATION BY A BRAIN SPECIFIC
MICRORNA MIR-128: FROM TARGETS TO BEHAVIOR
Chan Lek Tan, Ph.D.
The Rockefeller University 2013
MicroRNAs constitute a vital new component of our evolving
understanding of regulatory mechanisms that shape cellular gene expression. As
ubiquitous regulators of protein translation, microRNAs have a unique
regulatory function that is only beginning to be fully described. In addition, their
role in the control of gene expression in neurons, which underpins neuronal
identity and information processing, has not been fully addressed.
In this thesis, I present studies that demonstrate a potent yet previously
unknown regulation of neuronal intrinsic excitability by the microRNA miR-128.
I show using genetic models that endogenous miR-128 plays a powerful role in
dampening the excitability of pyramidal projection neurons in the adult
forebrain and demonstrate that the loss of this microRNA alone results in severe
motor hyperactivity and fatal epilepsy. By employing genetic tools that permit
the interrogation of miR-128-mediated repression and its downstream
physiological effects in restricted neuronal populations, I show that miR-128
exerts a sensitive tuning control of target gene expression, intracellular signaling
cascades activation and behavioral measures of excitability.
The work presented here will help to guide future studies of microRNA
function in neurons and other cell types, and reveals a small RNA and its target
network as a novel regulatory node with possible implications in animal
behavior and human pathology.

To my late grandmother

李金梅
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Chapter 1: Introduction

1

In complex multicellular organisms, terminally differentiated somatic cells
are participants in a vast division of labor. These cells perform specialized tasks
that enhance the survivability and the fitness of the organism as a whole. The
role of most if not all of these cells can be simplified as follows:
1. Taking a measure of their environment by probing and measuring the
presence

of

external

signals

such

as

photons,

pressure,

metabolites,

neurotransmitters etc.
2. Responding to the combination of these inputs by changing their own internal
environment, producing a response that can be read by other cells and for some
cells issuing a response that alters the great Exterior itself.
3. Employing homeostatic control to ensure their ability to respond to further
inputs in a consistent manner.
For neurons of the central nervous system, the role is similar if somewhat
more elaborate. While the input is composed mostly of membrane potential
changes, chemical neurotransmitters and neuropeptides, the range of responses
is vast. Firstly, neurons integrate multiple inputs across the dendritic network to
transform input information. Secondly, neurons often engage cytoplasmic and
nuclear plasticity mechanisms to change their response to future inputs. Finally,
neurons require homeostatic controls that preserve not only their ability to
respond to further inputs, but also their capacity to re-engage plasticity
mechanisms to set down new and persistent changes.
In addition to the internal complexity of the singular neuron, the adult
brain of mammals consists of a daunting diversity of functionally unique
neuronal subsets. Cell types are characterized by stereotyped morphology,
regional and laminar location, connectivity and neurotransmitter output and
2

receptivity. The reductionist approach to neuroscience, which has proven
enormously useful in explaining animal behavior, requires careful accounting of
neuronal diversity as well as an understanding of how information is processed
in each subtype.
Both the neuronal identity and response profiles exhibited by each
neuronal subtype are greatly influenced by gene expression. The combination of
genes expressed, the quantity to which they are produced, the temporal pattern
and spatial localization of their expression, are all salient factors. It is not
surprising then that neuronal gene expression is regulated at multiple levels epigenetic, transcriptional, post-transcriptional and translational, each conferring
a unique regulatory function.
Among the post-transcriptional mechanisms discovered so far, a class of
small non-coding RNAs known as microRNA (miRNAs) has drawn particular
interest among neuroscientists. There exists a large number of unique miRNAs
many of which are expressed in the brain and exhibit neuronal subtype specific
expression patterns. This suggests a role in determining identity and/or shaping
cell-type specific processes, but only a handful of neuronal miRNAs have been
studied so far.
The work I present in this thesis aims to examine the functional
consequences of miRNA expression in neurons. It will examine the manner in
which miRNAs alter gene expression and affect physiology and information
processing in specific neuronal subsets. More generally, the results presented
here will improve our understanding of the multi-layered architecture of gene
expression in neurons and other cells.

3

In this introduction, I will briefly review the original discovery of the
miRNA system, outline the current understanding of miRNA biogenesis and
function, discuss key miRNA regulatory motifs, and review current knowledge
of miRNA function in neurons.
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1.1 microRNAs: a novel small RNA family
The compendium of genetically encoded small noncoding RNAs in
animals encompasses a growing list of unique classes, including piwi-interacting
RNAs (piRNAs) (1) , pseudogene derived endogenous siRNAs (endo-siRNAs)
(2), and microRNAs (miRNAs). Among these, miRNAs represent arguably the
most ubiquitously expressed class of small RNAs, as well as the most intensely
studied.
The first miRNAs let-7 and lin-4 were discovered in nematode worms (C.
elegans) as a result of genetic screens for novel heterochronic genes. let-7 and lin-4
were found to regulate the timing of larval cell fate decisions, by repressing
translation of protein-coding messenger RNAs (3-5), demonstrating in animals a
unique form of small-RNA mediated post-transcriptional regulation.
Soon after, studies showed that miRNAs were more than simply an
esoteric innovation of invertebrate evolution. The broad conservation of let-7
throughout bilateran lineages and the detection of let-7 and other novel miRNAs
in a wide range of eukaryotic cells revealed miRNAs to be part of an ancient and
ubiquitous regulatory mechanism (6-10). These efforts in addition to deep
sequencing studies have identified hundreds of miRNAs in humans and mice,
including both highly conserved miRNA families as well as species-specific
members (11-13). The latest update in miRBase (www.mirbase.org), a
comprehensive miRNA database, lists over 1200 miRNAs and over 2000
miRNAs in the mouse and human genomes respectively.

5

The discovery of miRNAs was contemporaneous with the seminal
discovery of RNA interference (RNAi), a post-transcriptional sequence-specific
mechanism of gene silencing through exogenous introduction of double stranded
RNA (dsRNA) (14).
Starting with double stranded RNA, RNAi involves small interfering
RNA (siRNA) intermediates of 22-26 nucleotide length, which mediate
degradation of transcripts with complementary sequences. Sequence analysis of
miRNA loci and biochemical isolation of miRNA intermediates revealed that
miRNA production also involved a double stranded precursor in the form of a
hairpin structure. These structural parallels between siRNA and miRNA
immediately suggested the possibility of common mechanisms of biogenesis.
Mechanistic links between the two were formally demonstrated by a common
requirement for Dicer and Argonaute family proteins (15-18). Other steps
required for the maturation of functional miRNA, from transcription to
incorporation into effector complexes, were discovered soon after. The canonical
pathway of miRNA production in mammalian cells that evolved as a result is
outlined below.

6

1.2 Biogenesis and decay
miRNA loci are distributed in multiple locations across the genome.
About half of these loci are located in intergenic regions and have unique cisregulatory sequences such as enhancers and promoters (19). Other miRNAs are
located in the introns of protein coding genes and are generally co-expressed
with their host genes. In both cases, miRNAs can occur either singly or as one of
many in a poly-cistronic cluster, with multiple hairpins located on one
continuous primary RNA transcript (pri-miRNA).
Systematic studies of expression patterns of miRNAs and host genes show
strong co-expression between closely spaced miRNAs and between intronic
miRNAs and their host genes (20). This could result from their expression from a
single transcript, or simply reflect the existence of common cis-regulatory
regions. Like protein-coding mRNA, the vast majority of pri-miRNAs are
transcribed by RNA polymerase II (Pol II) (21, 22), although RNA polymerase III
(Pol III) promoters have been detected in association with some miRNAs (23, 24),
and are likely to support higher transcription rates at these loci.
Regardless of their genomic location, further processing of miRNAs
requires the formation of a hairpin structure called the precursor miRNA (premiRNA), which includes an imperfectly complementary double stranded stem
and a terminal loop. The mature miRNAs are derived from one or both strands
of the stem region.

Pre-miRNAs are processed from pri-miRNA co-

transcriptionally by the nuclear Microprocessor complex (25). This complex
consists of two core-proteins: DGCR8, which binds to the hairpin stem loop and
Drosha, which catalyzes the cleavage of the pre-miRNA from the rest of the
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transcript (26, 27). For intronic miRNAs, precursor cleavage occurs after the
assembly of exon-junction complexes but before excision of introns (28), ensuring
that accurate mRNA splicing can occur despite the presence of intronic miRNAs.
Pre-miRNAs are exported to the cytoplasm by the GTP-dependent
karyopherin protein Exportin5 to be processed and incorporated into the RNAinduced silencing complex (RISC). Pre-miRNAs are processed by the RISCloading complex (RLC), which consists of 3 core proteins - Dicer, TRBP and
Argonaute (Ago) (29). Dicer catalyzes a second cleavage step to generate a
double stranded intermediate analogous to siRNAs. This miRNA/miRNA*
duplex is then loaded onto Argonaute, the core miRNA-mRNA binding subunit.
Selection of the effective strand of the duplex is thought to be a stochastic process
with strand use bias determined by the relative thermodynamic stability of the 5'
ends (30, 31). Finally, Ago catalyzes the unwinding of the duplex in an
endonuclease-independent

mechanism

(32-34)

to

complete

the

miRNA

maturation process.
Major deviations from the above canonical pathway (Figure 1) for miRNA
production have been shown to exist in mammals, however these cases are
extremely rare. Drosha-independent processing has been demonstrated for a
subclass of miRNAs called mirtrons in which short intronic miRNA hairpins are
excised from pri-miRNA using components of the splicing machinery (35, 36).
Furthermore, it was demonstrated recently that processing of the mammalian
miRNA miR-451 is Dicer-independent. Instead, pre-miR-451 cleavage requires
Ago2 endonuclease activity (37-39).

8

Figure 1. Canonical biogenesis of miRNA

Figure 1 Canonical biogenesis of miRNA.
Pol II transcribes most intronic and intergenic miRNAs into pri-miRNA
transcripts, which may contain one or multiple hairpins. Pre-miRNA hairpins are
cleaved from pri-miRNAs by the Microprocessor complex, and are exported
from the nucleus by Exportin5. Pre-miRNAs are further cleaved and unwound
by RLC. Finally, mature single stranded miRNAs are loaded into Argonautecontaining RISC complexes.
9

Unlike miRNA biogenesis, relatively little is known about the regulation
of miRNA degradation. Experiments that track the loss of mature miRNAs upon
Dicer deletion in vivo and in cell culture suggest that miRNAs can be very longlived. Variation in stability between miRNAs can be substantial. For example,
Dicer deletion in mature Purkinje cells of the cerebellum resulted in complete
absence of miR-124a at the earliest observation time point (2 weeks after
deletion), but other miRNAs appear to persist for weeks (40). Measurements of
miRNA decay rates upon Dicer deletion in mammalian fibroblast culture
produced an estimated average half-life of 5 days but with substantial variation
between miRNAs (41).
Other studies however have shown that miRNA stability is strongly
dependent on cellular state, and in some cases turnover can be very rapid.
miRNAs appear to have higher decay rates in cycling cells and greater stability
upon mitotic arrest. Interestingly, decay in neurons appears to be activitydependent. Glutamate-induced neuronal activation enhances miRNA decay,
such that most expressed miRNAs have high turnover rates in hippocampus and
cortical neurons (42).
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1.3 miRNA target binding
The RISC complex with a single stranded 19-22 nucleotide mature miRNA
is the primary effector complex in miRNA-mediated post-transcriptional
repression. miRNAs serve as guide strands for RISC complexes, allowing
binding to target mRNAs through partial sequence complementarity.
This partial complementarity between miRNA and target has been
dissected to reveal the structural factors that contribute to functional binding.
miRNA bases 2-7 from the 5' end define the minimal seed sequence, and perfect
complementarity between the seed and target mRNA is the most important
criteria for effective binding (43-45). Imperfect complementarity outside of the
seed region may contribute to binding efficiency, but the effect is small and only
in rare cases do such binding compensate for the lack of perfect seed
complementarity. This requirement of seed binding has since been validated by
structural studies (46-49). The major contribution of the seed sequence to target
specificity has led to the classification of miRNAs into related families in which
miRNAs share identical or highly similar seed sequences and are therefore likely
to have highly overlapping target sets.
In addition, RISC binding is influenced by the context of the target site
within the transcript. Repression is favored by the following structural factors
that reduce physical occlusion of RISC-binding and improve accessibility of
secondary structures: (i) Target site location in the 3'UTR as opposed to coding
region or 5'UTR. (50, 51) (ii) Location of seed site within the beginning and end of
3'UTR of mRNA (52, 53), and (iii) Uracil and adenosine rich context of the seed
(53-55). Lastly, most transcripts contain many potential miRNA target sites, and
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often multiple target sites for one miRNA.
Binding of a single transcript by multiple RISC-complexes unsurprisingly
increases the repressive effect. Biochemical analysis reveals that while most of
these interactions occur in an independent and non-cooperative manner (53, 55),
sites spaced between 13-35 nucleotides apart result in cooperative repression (53,
56, 57).
The specific sequence requirements of seed complementarity and other
sequence-based

determinants

of

miRNA

binding

have

encouraged

a

proliferation of prediction algorithms to identify targets in-silico. In addition to
combinations of the above factors, many of these programs employ measures of
site conservation to improve selectivity for biologically functional sites.
Furthermore, most algorithms attempt to rank predictions based on scores
generated for some of the above factors as well as others such as predicted
miRNA-target pairing stability.
The resulting lists of predicted targets are largely overlapping due to the
requirement of seed pairing but contain important differences related to
variations in weighting factors, and the use of different transcript databases.
Recent studies that rate the performances of these algorithms against
experimental data largely demonstrate a significant but weak correlation even
for the best performing algorithms, with false positive rates exceeding 50% (58).
Such a result is perhaps unsurprising given that the algorithms employ only
general targeting principles, most of which were derived from cell culture
experiments involving highly expressed miRNAs.
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Among the other factors that remain unaccounted for in most predictive
algorithms, I will highlight three salient ones here. Firstly, many RNA-binding
proteins regulate transcript localization and stability. How and if these proteins
interact with RISC complexes is still largely unexplored. Secondly, cell-type
specific expression of miRNAs and mRNAs can result in large variations in
miRNA-target ratios and differing combinations of miRNAs available to target a
given transcript. Finally, the mechanisms mediating miRNA-dependent
repression (e.g. stability of translationally repressed transcripts) may be species
and cell-type specific. As such the degree of repression experimentally observed
will depend on the way in which miRNA levels were perturbed and the manner
in which these observations were taken, e.g. protein versus mRNA
quantification.
Given the limited utility of predicted targets in light of these factors,
recent studies have tried to identify in-vivo interactions by isolating RISC
complexes and their associated RNA (59, 60). These early studies also had limited
success due the an apparent promiscuity of miRNA-transcript interactions.
Subsequent iterations have improved the specificity and reduced false positive
rate.
One such example (HITS-CLIP) uses UV-crosslinking of Ago to bound
RNA followed by isolation and sequencing of bound mRNA (61, 62). The
authors' own comparison with genome-wide protein quantification of miRNA
repression suggests an improvement of false positive rate to ~30%. The technique
was applied to identify miRNA targets in embryonic stem cells and in neurons
(61, 63). This technique however is limited by the low efficiency of UVcrosslinking and low RNA yield.
13

An alternative technique (PAR-CLIP) uses a photo-activatable nucleoside
to facilitate the formation of mRNA-Ago covalent links. This technique also
permits subsequent identification of the cross-linked nucleotide and therefore
allows the exact Ago-RNA binding site on the transcript to be readily identified
(64). The major limitation with this protocol is the requirement for synthetic
nucleosides, which limits its application to cultured cells.
Finally, even the presence of Ago-miRNA-mRNA association in-vivo does
not in itself imply target repression. At least one experimental comparison
between mRNA target repression and target association using both HITS-CLIP
and PAR-CLIP has been performed (65). The results suggest that while both
CLIP techniques show good agreement, and outperformed most predictive
algorithms, only 50% of predicted targets were repressed by exogenously
applied miRNA.
In conclusion, substantial progress has been made in elucidating the basic
determinants of miRNA-target pairing but transcript and cell specific
determinants are not readily accounted for. New tools like HITS-CLIP and PARCLIP permit unbiased discovery of physiological miRNA-target interactions,
however, only subsets of these interactions result in target repression, implying
the need for independent assessments of target repression.
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1.4 microRNA-mediated repression
In the vast majority of cases, miRNA-RISC binding results in
downregulation of the target gene through translational repression and/or
mRNA deadenylation and degradation (Figure 2). Extensive complementarity
between miRNA and target RNA can result in Ago2-dependent endonucleolytic
cleavage and degradation of the target as in RNAi (66) but this is rarely observed
in animals.
Initial analysis of translation repression suggests that miRNA repression
did not result in changes in polysome distribution of the target mRNA and that
repression occurred at a post-initiation step, likely by stimulating ribosome drop
off during polypeptide elongation (67, 68). Subsequent studies however, have
provided heavy evidence in favor of inhibition of translational initiation as a
major mechanism of repression. Firstly, endogenous mRNA targets shift to
lighter polysome fractions upon miRNA-repression (69, 70). Secondly, 5' m7G
cap-independent translation is not subject to miRNA repression (71, 72).
Furthermore,

in

vitro

reconstituted

translation

experiments

have

also

demonstrated the importance of initiation mechanisms involving the mRNA 5'
m7G cap (72-74). Finally, structural studies show that the Mid domain of
Argonaute proteins can bind directly to the 5' m7G cap (75).
Although miRNAs were initially thought to regulate translation with
minimal effect on mRNA level, many subsequent microarray and reporter
construct experiments show that target silencing is accompanied by mRNA
degradation. The consensus mechanism for this involves Ago binding of GW182
and PABP which in turn recruits decapping and deadenylase enzymes to initiate

15

Figure 2. Modes of miRNA repression

Figure 2. Modes of miRNA repression.
RISC binding to 3' untranslated region of messenger RNAs results in protein
output repression by two non-mutually exclusive mechanisms. Argonaute
proteins block translational initiation possibly by binding 5' cap structure and
blocking recruitment of cap-dependent initiation factors. Argonaute also recruits
decapping and de-adenylation enzymes via GW182 proteins to initiate mRNA
degradation.
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mRNA decay (76, 77). It remains unresolved whether translational inhibition and
mRNA degradation are mechanistically coupled or independent. Based on
kinetic experiments, it appears that inhibition of initiation occurs more rapidly
than mRNA decay, suggesting that the former precedes and perhaps triggers the
latter. As mRNA 3'UTRs also contain other cis-regulatory sequences that may
recruit other RNA-binding factors, it is also likely that the relative contribution of
inhibition and decay to the overall steady state repression is transcript and
context specific.
More recently, genome-wide studies have sought to address this issue by
quantifying concurrent changes in protein output, mRNA-ribosome association
and mRNA level upon exogenous miRNA perturbation (58, 78-80). These studies
indicate a strong correlation between changes in protein and mRNA levels. They
also show that the repression of protein output is mildly but consistently higher
than that of mRNA reductions, demonstrating that mRNA decay is a major
component of repression but insufficient to account for miRNA effects alone. The
result of these studies also confirms what had been observed with microarraybased quantification of target mRNAs. miRNA repression produces very mild
(nearly all less than 2 fold, majority less than 1.5 fold) effects on steady state
levels of both mRNA and protein.
In conclusion, miRNA repression in mammalian cells is likely to involve
translational initiation inhibition followed by mRNA decay. In addition, miRNAmediated repression is generally mild and repressive effects may not be captured
by mRNA quantification alone.
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1.5 Regulatory motifs and physiological roles
Despite the increasing complexity emerging around the regulation of
specific miRNA production and function, the core principle of miRNA-mediated
function is simple: miRNAs serve as guide strands to target multiple transcripts
for repression. miRNAs bear some similarities to protein transcription factors:
they can inhibit expression of hundreds of genes based on sequence
determinants, and do so in combination with other miRNAs to increase
specificity of regulation.
In this framework, the roles of some miRNAs are analogous to that
ascribed to transcription factors, for example as binary switches during cellular
differentiation. Such a classical switch interaction is exemplified by the first
known miRNAs lin-4 and let-7, which are expressed to turn off specific target
genes so as to alter cell fate decisions (3). Such a switch-like role for miRNAs has
been observed during the differentiation of murine epidermal cells (81), smooth
muscle cells (82) and neurons (83, 84). Similarly, miR-145 promotes
differentiation of human embryonic stem cells by repressing pluripotency factors
(85). Finally, comprehensive examinations of miRNAs and conserved targets
show that they are usually expressed in a mutually exclusive manner (86, 87),
suggesting that miRNA switches are common regulatory motifs throughout
animal development.
In the above switch-like interactions, miRNAs are strongly induced
during the cell fate transition and markedly repress the putative relevant targets,
but miRNA expression alone is not generally sufficient to trigger the transition.
In fact, premature miRNA expression often results in dysfunction of the
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progenitor cell such as reduced proliferation (81, 84). It is therefore possible that
miRNAs more generally improve the robustness of the cell fate transition by
suppressing genes that are detrimental to the transition process. In agreement
with this, miR-9a is not induced during differentiation of neuronal precursors
but its presence reduces phenotypic variation by helping to suppress targets
below a threshold level. (88).
Such failsafe interactions suggest a broader utility of miRNAs as a buffer
against phenotypic variation in general (89). Phenotypic variation might arise
from intrinsic transcriptional noise. Transcription is an inherently noisy
stochastic process (90) and phenotypically identical cells masks substantial cellcell expression differences (91). Increased stochastic variability in gene
expression can be detrimental, and protein networks are organized to buffer
against it (92). In support of this theory, miR-7 is required to maintain cell fate
decisions in the presence of temperature fluctuations, which increases the
stochasticity of gene expression (93).
These switch-like and buffer-like regulations reduce target proteins below
a threshold, so as to trigger or sharpen a binary process. The mild influence of
miRNA on the expression of most protein targets suggests that fine-tuning of
cellular processes is another important regulatory motif. In this context, the
protein targets are expressed at a defined optimal range by one or more
miRNAs, and deviations above and below this range are both detrimental. This
form of regulation has been observed in a number of terminally differentiated
cell types. For example, miR-181 regulates T-cell sensitivity, while miR-223
regulates neutrophil sensitivity. In Drosophila, miR-8 tunes the levels of atrophin
to regulate neurodegeneration (94).
19

Recently, studies have begun to reconcile these different modes of
interactions found in mammalian cells. When considering target changes in large
cell populations, as is the case in many murine experiments, theoretical analysis
suggests that buffering of small stochastic transcriptional noise can be
accompanied by mild aggregate repression comparable to that associated with
fine-tuning effects (95). This indicates that tuning interactions found in
population based measurements does not exclude the possibility of buffering
effects in single cells.
This notion has found experimental support recently. Using single-cell
measurements, Mukherji et al. showed that while aggregate repression is
modest, large variations in repressive effect occur between cells. They further
demonstrate that switch-like and fine-tuning interactions may occur for the same
miRNA-target pair depending on the relative abundance of miRNA and mRNA
target under a given condition (96). It is also likely that in different cell types,
miRNAs target not just different mRNAs but regulate them in different manner,
limiting the generalizability of specific miRNA-target interactions drawn from
studies performed in cultured cells or in one cell type.

20

1.6 microRNAs in neurons: expression and function
Post-transcriptional mechanisms are important in the regulation of
neuronal physiology and information processing. For example, proteins like
FMRP regulate the translation of specific genes while proteins such as TSC
control global translational output, and deficiency of either results in severe
cognitive and neurological defects. As post-transcriptional regulators, miRNAs
are similarly critical to the function of neurons.
Since the maturation of nearly all mammalian miRNAs are dependent on
the canonical pathway outlined before, animals deficient for one or the other of
these pathway components provided some of the first demonstrations of the
importance of miRNAs in mammalian neuronal physiology.
Loss of Dicer enzyme is embryonic lethal (97), therefore conditional
deletions of Dicer have been used to study the role of miRNAs in several brain
regions and neuronal populations. These mutants show that miRNAs have a
important role in neuron survival. Specific loss of Dicer in a variety of neuronal
populations (including cerebellar Purkinje cells, forebrain principal neurons,
midbrain dopamine neurons and retinal cells) consistently led to increased
apoptosis and cell death (40, 98-100).
Other deficiencies that result in only partial miRNA depletion have been
useful to reveal milder phenotypes. Haplo-insufficiency of the Microprocessor
component and Drosha binding partner DGCR8 impairs biogenesis of a subset of
miRNAs in the adult brain and resulted in behavioral and cognitive deficits
reminiscent of human 22q11.2 microdeletions (101). Loss of Ago2 in Dopamine
receptor 2 (Drd2) positive neurons in the striatum results in partial depletion in a
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subset of expressed miRNAs, and reduced cocaine addiction (102).
More recently, several groups have focused on specific miRNAs (103) and
I will highlight a few below. Overexpression of miR-125b induces the formation
of long thin spines and reduced mEPSC amplitude, while reduced miR-125b
increases the width of dendritic spines (104). miR-138 also negatively regulates
spine size and excitatory mEPSCs (105). Both studies examined miRNA function
in spine formation in cultured neurons.
Other studies have used knockdown of miRNAs in murine brain,
allowing further characterization in their physiological context and examination
of behavioral alterations. Overexpression of miR-137 in newborn cells in the
adult dentate gyrus reduced dendritic complexity and spine density (106), while
miR-134 is expressed near dendritic spines and negatively regulates spine size
(107). Interestingly, overexpression of miR-134 in the hippocampus abrogates
long-term potentiation in CA1 neurons, and impairs memory formation in the
contextual fear-conditioning paradigm (108). That study represented a rare
example in which perturbation of a single miRNA led to changes in learned
behavior. Another significant example is that of miR-212, which is induced by
extended cocaine self-administration in rats. Overexpression and knockdown of
miR-212 in the striatum results in reduced and enhanced cocaine intake
respectively (109).
In all the above case studies, miRNA knockdown was achieved by nongenetic means using modified RNA such as antagomirs and locked nucleic acid
(LNA) as well as miRNA-sponges. In contrast, far fewer genetic mutants of
specific miRNAs have been generated. A couple of unique difficulties make
genetic models of miRNA function challenging. Firstly, many miRNAs exist as
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multigene families, with distinct members expressed from multiple loci but
sharing very similar seed sequences, resulting in functional redundancy.
Secondly, many miRNAs are expressed in tightly spaced poly-cistronic
transcripts, making it difficult to delete one miRNA without affecting coexpressed miRNAs at the same locus. One notable example is that of the polycistronic transcript which expresses both miR-132 and miR-212. Deletion of the
entire locus in newborn hippocampal neurons resulted in dramatically reduced
dendritic length and spine density. The authors disentangled the relative
contributions of the two miRNAs by demonstrating that only miR-132 is
functionally expressed in these neurons (110).
Studies of changes in miRNA expression in pathological tissue from
human patients and disease model animals hinted at the clinical relevance of
these findings. Significant changes in miRNA levels were found in tissue samples
from patients of neurodegenerative diseases such as Huntington's disease and
Alzheimer's disease (111-113). Other changes have been noted in post-mortem
tissue from sufferers of schizophrenia and schizoaffective disorder (114, 115). In
spite of this, few specific roles have been attributed to miRNAs in the
modulation of either neurodegenerative or psychiatric disorders.
The above studies nearly always ascribe miRNA-dependent phenotypes
to single targets, often selected on the basis of predicted seed interactions and
shown to be plausible targets using reporter constructs in culture. The
contribution of single miRNA-target pairings to the observed effects is often not
directly addressed and when it is, has somewhat limited explanatory power.
Target discovery tools detailed in the previous sections have not been utilized in
the study of neuronal miRNAs. In summary, evidence of the various roles of
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miRNA in post-developmental neuronal function has accumulated in recent
years but there exist significant gaps in our current understanding.
In the following chapters, I will present the results of our study. First, we
demonstrate that changes in miR-128 levels in the principal projection neurons of
the forebrain sensitively tune motor activity and seizure susceptibility. Second,
we show that miR-128 is uniquely important in striatonigral projection neurons.
Third, we have found that miR-128 represses a specific subset of target genes in
this neuronal population. Lastly, we show that miR-128 regulates ERK signaling
and suppresses electrical excitability as well as transcriptional response.
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Chapter 2 miR-128: Expression and function in forebrain principal
projection neurons
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2.1 Spatial enrichment of a neuronal miRNA
A large body of work over the last decade has examined the expression
levels of a large and growing list of mammalian miRNAs in a nearly exhaustive
list of organs and tissues obtained at various developmental stages and disease
states.
A notable point that arises from these studies is the very high level of
tissue and developmental stage specificity to miRNA expression. Many wellestablished central nervous system (CNS)-specific miRNAs such as miR124a are
highly expressed at the earliest stages of neuronal differentiation and are likely to
have a most substantial role in developmental processes (116, 117). However,
these expression studies also consistently identify a handful of well expressed
miRNAs with specific expression in the mature CNS, suggesting an involvement
in the processes of neuronal information processing that underlie learning and
behavior. Among these, one specific miRNA, miR-128, exhibits an intriguing set
of characteristics.
Northern blot quantification of miRNAs from a panel of human and
mouse organs reveal a number of miRNAs that are brain specific in both species
including

miR-128,

miR9,

miR132,

miR137,

miR139

(118).

Microarray

quantification of miRNA in the developing and adult brain shows that a number
of miRNAs including miR-128, miR132 and miR29 among others are strongly
upregulated during development to reach peak expression levels in adult. (119).
Expression profiles based on cloning frequency reveal that miR-128 and miR143
are enriched in the adult cortex, striatum and hippocampus compared to the
embryonic brain and various neuroblastoma and glioblastoma cells (120).
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Our own quantification of miR-128 levels using semi-quantitative RT-PCR
shows that miR-128 is expressed in the CNS at higher levels than any other organ
examined (Figure 3a). miR-128 expression begins just before birth and accelerates
rapidly after birth into adulthood after which it remains at peak levels (Figure
3b).
Although hundreds of bona fide miRNAs have been identified from
mammalian tissue, a majority is expressed at very low levels and only a few
dozen are consistently expressed at high levels in one or more tissues.
Differences in expression levels often span a few orders of magnitude. Using
absolute quantitation with RT-PCR and synthetic miRNA mimics, we found that
the expression of miR-128 in the adult brain is very high (~104 per cell) (Figure
3e), comparable to the expression of ubiquitous miRNAs such as let-7 (121).
miR-128 appears to be a vertebrate innovation, as it has been identified in
the lamprey genome but has not been identified in any invertebrate genome so
far. In most vertebrates, miR-128 is expressed from hairpins encoded at two
distinct loci: miR-128-1 and miR-128-2, which are located in the longest introns of
two related protein coding genes (R3Hdm1 and Arpp21 respectively). Both
proteins share a common putative RNA-binding R3H domain.
Sequence divergence of the hairpins is nearly identical to sequence
divergence of the protein coding host genes, suggesting that the association
between miR-128 and members of the R3H domain protein family formed before
duplication of the ancestral loci.
Interestingly, studies examining the distribution of miRNA expression in
the adult and developing zebrafish CNS show that the highest expression was
detected in adult forebrain structures including the telencephalon (122, 123). In27

situ hybridization studies using LNA probes against mature miR-128 show that
expression is higher in forebrain structures such as olfactory tubercle, cortex,
striatum and the hippocampus (Figure 3c,d). The high and restricted miR-128
expression pattern, as well as the conservation of this pattern across the
vertebrate lineage, strongly suggests an involvement in post-developmental CNS
function.
Recently developed techniques extend these expression studies by
profiling miRNAs expressed in genetically-defined neuronal populations. One
such study showed that, within the cortex, excitatory Calcium-calmodulin kinase
2a (Camk2a)-positive neurons expressed much higher levels of miR-128 than
inhibitory GAD-positive neurons, indicating a greater spatial specificity than
previously appreciated. Among miRNAs expressed in Camk2a-positive neurons,
miR-128 is one of the most highly expressed (124).
While this and other previous studies have quantified the relative
expression of miRNAs among related cell or tissue types, it remains unclear what
the significance of these differences in expression levels might be, especially in
relation to the number and distribution of targets and in relation to the strength
and kinetics of repression. One alternative to expression profiling to gauge the
relative functional importance of miRNAs is to examine in-vivo targeting of
messenger transcripts, for example quantifying the density of targets of a given
miRNA among the set of all Ago-RISC bound transcripts.
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Figure 3. Postnatal forebrain enrichment of miR-128.
a, Expression levels of mature miR-128 were quantified by qRT-PCR from organs
of adult mice and expressed relative to the mean levels in liver. (n=2).
b, miR-128 and neuronal miRNA miR-124a in adult and embryonic brain (E12)
were quantified as in a and expressed as fold increase over expression levels in
the embryonic brain (n=3).
c, Expression of miR-128 in adult brain shown by in-situ hybridization on sagittal
brain slice using antisense LNA-probe to mature miR-128.
d, miR-128 levels in selected brain regions were quantified by qRT-PCR and
expression levels are expressed relative to mean hippocampus expression. (n=3).
e, Absolute quantification of miR-128. Titration standard (left) showing qRT-PCR
cycle number for varying concentrations of synthetic mature miR-128 (left).
Estimated per-cell copy number of miR-128 in adult striatal samples (n=16)
(right) assuming an average of 15 pg total RNA per cell. Bold line indicates
sample mean.
Error bars show s.e.m.
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Figure 3. Postnatal forebrain enrichment of miR-128.
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2.2 CLIP-Seq isolation of miRNA targets in projection neurons
To do this we made use of data generated by visiting student Morten
Venoe here in the lab, who identified Argonaute binding sites on expressed
transcripts in mature projection neurons. Briefly, we generated mice that permit
conditional Cre-dependent expression of Argonaute2 (Ago2) protein tagged with
a Flag epitope. Transgenic mice were crossed to mice expressing the Cre
recombinase in Camk2a-positive neurons, generating doubly transgenic animals
in which tagged Ago2 was expressed only postnatally in projection neurons of
the cortex, hippocampus and striatum. Ago-bound and protected RNA
sequences were isolated using an adapted protocol similar to one published
previously (63): starting with dissected and homogenized half forebrain samples,
RNA transcripts were UV-crosslinked to bound protein, unbound RNA was
digested, and tagged Ago2 protein was immuno-precipitated using antibody
against the Flag epitope. Adaptors were ligated to both ends of the RNA
fragments in the immuno-precipitated fraction and RNA was de-crosslinked
from protein by protease digestion. RNA fragments were then sequenced,
processed for quality and trimming of adapter sequences, and aligned to the
mouse genome (mm9) (Figure 4a).
The dataset of sequenced fragments forms clusters of overlapping RNA
fragment reads that correspond to putative sites of miRNA-RISC binding (Figure
4b). As the miRNAs that mediate the binding to each cluster cannot be
definitively determined from the data, we made use of the fact that most miRNA
targeting is determined by the minimal seed site hexamer (125). The candidate
miRNA(s) potentially mediating Ago-RISC targeting to each cluster can be
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Figure 4. Ago2 associated mRNAs in Camk2a-positive projection neurons.
a, CLIP-seq bound sites are enriched in 3'UTRs of mRNAs. The distribution of
the mouse (mm9) genome (left) and CLIP-seq read clusters (right).
b, Example CLIP-seq cluster of sequenced reads on the 3'UTR of Slc39a13 gene,
with a miR-128 6mer target site indicated below.
c, Scatter plot showing statistical enrichment of all 4096 possible 6mers in CLIPseq clusters located within Refseq annotated 3’UTRs. x-axis shows z-score which
is the number of standard deviations the observed frequency of a hexamer
exceeds the normalized frequency of occurrences in the corresponding RefSeq
region. y-axis shows -log(p-value) from chi-squared test. Hexamers enriched
above Refseq background are shown as grey dots; 6mer complementary to the
miR-128 seed is highlighted in red. Green line represents Bonferroni-corrected
critical p-value: 0.05/(46)= 1.22x10-5.
d, Distribution of cluster read-count among miR-128 CLIP-seq targets, defined as
genes with miR-128 target 6mer-containing CLIP-seq clusters within their
3'UTRs. Genes are ranked by total associated read-counts from left to right and
read-counts for each gene are shown.
e-f, Genes with above-average CLIP-seq cluster read-counts are associated with
neurological

disorders

and

neurotransmission.

Functional

annotations

significantly associated with miR-128 CLIP-seq targets shown in d were obtained
by IPA Ingenuity analysis and the median and average per-gene read counts for
each annotation are shown in scatter plot (e). Annotations associated with high
read counts are highlighted, all other annotations are shown in grey circles.
Specific highlighted annotations are shown with associated gene count, p-value,
and median and average read-counts (f).
Figures a-c courtesy of Morten Venoe.
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Figure 4. Ago2-associated mRNAs in Camk2a-positive projection neurons

33

identified by the presence of hexamers complementary to the miRNA seed site
within each cluster. Consequently, the potential in-vivo targets of each miRNA
can be determined.
Analysis of the combined sequence space given by all read clusters was
performed to determine if any particular hexamer sequence was enriched in
Ago-bound sites over the corresponding genomic region (3'UTR) as a whole. The
hexamer corresponding to the binding complement of the miR-128 seed was the
most enriched hexamer sequence (Figure 4c). Targets of miR-128 are therefore
among the most over-represented miRNA targets among all neuronal Agobound transcripts.
The targets of miR-128 include 707 unique target genes (Figure 4d), whose
roles encompass a substantial range of neuronal processes based on literaturecurated functional annotation-IPA (Ingenuity® Systems, www.ingenuity.com).
To parse the relative importance of these functional annotations, we examined
the read count density of each target. Targets with higher read count density are
deemed to be more likely to be functionally relevant. The median read count of
each cluster is 26, with a surprisingly wide range of up to hundreds of reads.
Since each functional annotation is based on a defined subset of target genes,
each of which can be assigned a read count, we calculated the average and mean
read counts associated with each annotation. We have plotted the average and
median gene read counts on a scatter plot, with each point representing a single
annotation (Figure 4e,f).
This analysis of miR-128 targets suggests that miR-128 is likely to have
important roles in neuronal plasticity and in disorders such as seizures and
motor disorders. We address this hypothesis in the following chapter.
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2.3 miR-128 expression in projection neurons suppresses spontaneous seizures
and locomotor activity
To assess the effect of miR-128 levels on neuronal physiology and the cell
specific role of miR-128, we generated mouse models that permit the conditional
deletion of the miR-128 loci as well as the conditional overexpression of miR-128.
For the deletion models, we generated mice carrying floxed alleles of each
of the two miR-128 loci (Figure 5). These alleles contain loxP sequences that flank
the miRNA hairpins, enclosing the 1-kilobase region centered on the 2 hairpins.
The presence of loxP sequences permits excision of intervening sequences by Cre
recombinases which are expressed in a cell-type specific manner, thus allowing
for the genetic deletion of miR-128 hairpins in restricted cell populations. The
presence of modified alleles in our mice models was confirmed by Southern blot
analysis against genomic DNA with an external probe, as well as by PCR
amplification and sequencing of modified regions. Regular genotyping was
performed with PCR reactions that permit rapid identification of wild type,
floxed and null (excised) alleles.
Crossing targeted floxed mice to transgenic mice ubiquitously expressing
Cre-recombinase generated germline deletions of both loci. Examination of null
mutants revealed a heavy bias in loci contribution to mature miR-128 levels in
the brain. Deletion of miR-128-2 reduced brain miR-128 levels by 80% while
deletion of miR-128-1 produced reductions of only 20% (Figure 6a-c). In addition,
the heterozygous condition resulted in approximately half the depletion
compared the null condition. These data suggest that no significant
transcriptional/processing compensation occurs in the absence of one miR-128
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Figure 5. Deletion targeting strategy.

Figure 5. Deletion targeting strategy.
Targeting strategy for miR-128-1 (left) and miR-128-2 (right) loci. 1 kb region
containing the miRNA hairpin was flanked with loxP sequences to generate miR128-1fl/fl and miR-128-2fl/fl mice. miRNA hairpin (blue rectangles); exons (grey
rectangles); loxP sites (black triangles); DTA - diphtheria toxin gene; TK thymidine kinase gene; LAH/SAH - long/short arms of homology. Neomycin
resistance gene flanked by frt sequences (black circles) was removed from
targeted locus in vivo using Flp recombinase transgenic mice. Modified alleles
were identified by probing EcoRI or SacI digested genomic DNA with DNA
probes 1 and 2, respectively (black rectangles).
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Figure 6. miR-128 levels are reduced by miR-128-1 and miR-128-2 deletion.

Figure 6. miR-128 levels are reduced by miR-128-1 and miR-128-2 deletions.
a, Mating scheme for generation of germline and postnatal deletions.
b, miR-128-2 is the dominant locus. miR-128 levels in the brains of miR-128-1-/and miR-128-2 mice were assayed by qRT-PCR and expressed relative to mean
wildtype levels. n=3-5.
c, Germline and neuronal deletion of miR-128-2 result in similar reductions of
miR-128 levels, n=4-5.
d, , Levels of other miRNAs were unaffected in the absence of miR-128-2. miRNA
levels from Camk2a mutants and controls (n=2) were quantified by Taqman Low
Density qRT-PCR arrays. Scatter plot shows normalized expression levels given
by delta Ct (raw cycle count - global average cycle count) in mutant and control
samples. Dotted lines indicate 2 fold increase or decrease relative to control. Red
dot corresponds to mature miR128.
Error bars show s.e.m.* p<0.05; ** p<0.01; *** p<0.001, Welch's t-test.
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allele. Due to the dominant contribution of miR-128-2, all deletion mutants
mentioned subsequently in this thesis will refer to this locus alone unless
otherwise stated.
For the conditional overexpression models, we used homologous
recombination to insert a transgene segment into an intron of the ROSA26 gene,
which is ubiquitously expressed (Figure 7a). The transgene consists of a strong
CAG promoter (a combination of cytomegalovirus early enhancer element and
chicken beta-actin promoter), a transcriptional STOP cassette flanked by loxP
sequences, and a 1 kilobase genomic sequence that includes the miR-128-2
hairpin. In the absence of Cre recombinase expression, the STOP cassette
terminates transcription upstream of the miR-128-2 hairpin. In the presence of
Cre recombinase, the STOP cassette is excised and strong transcription of miR128-2 hairpin occurs. Gene targeting was confirmed by Southern blot analysis
using an external probe and PCR amplification and sequencing. Modified locus
was followed by PCR-based genotyping. Cre-dependent expression of miR-128
was confirmed in both embryonic stem cells and in the adult brain. The level of
overexpression in the brain was mild, possibly due to the high endogenous levels
already present (Figure 7b,c).
Examination of these miR-128 mutants demonstrates that miR-128
regulates seizure susceptibility and motor functions. While miR-128-2 null
mutants were fertile and viable, they had severely restricted lifespans, with a
median of about 55 days (Figure 8a). We suspected that mutants had succumbed
to seizures as home cage deaths were sudden and spontaneous and exhibited
postural signs of seizures such as extended posture. Continuous video recording
of mutants in the home cage captured intermittent bouts of severe spontaneous
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Figure 7. Targeting strategy for transgenic expression.

Figure 7. Targeting strategy of transgenic expression.
a, Left: Targeting strategy for conditional overexpression of miR-128 using
knock-in transgenic strategy at the ROSA26 locus. A 1-kb region that includes the
miR-128-2 hairpin (red rectangle) was cloned downstream of a strong CAG
promoter and a floxed-STOP-Neomycin cassette. Modified allele was identified
by Southern blot (top right), or PCR genotyping (bottom right).
b, Mating scheme for postnatal neuron-specific overexpression of miR-128.
c, miR-128 levels in striata of double transgenic (Camk2a-cre; ROSAmiR-128/miR-128),
single transgenic (Camk2a-cre; ROSA+/miR-128), or wild type mice (n=3 each) were
measured by qRT-PCR. Error bars show s.e.m. * p<0.05 Welch's t-test
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tonic-clonic seizures (Figure 9a). Strong seizure episodes preceded deaths of
recorded mutants. Consequently, we were able to rescue survival by continuous
administration of the anti-convulsant valproate, demonstrating that fatalities
resulted from a severe epileptic condition (Figure 9b).
Furthermore, miR-128-2 null animals were significantly more hyperactive
than wild type animals in the open-field chamber (Figure 8b,c). For open-field
chamber quantification, horizontal distance traveled was measured over an hour
for animals exposed to a novel chamber. Mutants treated with valproate also
remained hyperactive, suggesting that hyperactivity was not dependent on the
development of prior seizures (data not shown). In agreement with the low
expression at the miR-128-1 locus, deletion of this locus produced no significant
hyperactivity and no increases in mortality (data not shown).
Using cell-type specific isolation and quantification of Ago-associated
miRNAs, a previous study had shown that miR-128 was highly enriched in
Camk-positive excitatory neurons compared to GAD-positive inhibitory neurons
(124). Given that result, in combination with our observation that miRNA targets
in Camk2a neurons were highly enriched for miR-128 targets, we hypothesized
that deletion of miR-128 in this neuronal population alone might recapitulate
most if not all of the observed mutant phenotypes.
Projection neuron-specific deletion of miR-128-2 was generated by
crossing floxed mice with mice expressing Cre recombinase in Camk2a neurons
(Figure 6a). Cre expression was present in principal neurons of the cortex and
hippocampus as well as medium spiny neurons of the striatum. Cre expression
starts in the first week after birth and reaches maximum at P15, allowing
temporal restriction to to post-migratory mature neurons (126).
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Figure 8. Germline and neuron-specific deletion of miR-128-2.

Figure 8. Germline and neuron-specific deletion of miR-128-2.
a and d, Premature mortality. Kaplan-Meier plot showing percentage of
surviving animals as a function of days after birth in a, germline deletions: miR128-2-/- (n=20, median 55 days), miR-128-2+/- (n=49), miR-128-2+/+ (n=46).
p<0.0001, log-rank test, and in d, postnatal neuron deletions: Camk2a-cre; miR128-2fl/fl (n=25, median 56 days), Camk2a-cre; miR-128-2wt/fl (n=26), wild type
controls (n=68). p<0.0001, log-rank test.
b, c, e and f, Increased motor activity. b and e, Total horizontal distance travelled
in open field chamber over 60 minutes. c and f, Total vertical episodes (rearing)
in open field chamber over 60 minutes. b and c, miR-128-2-/- (n=12), miR-128-2+/(n=14) and wild-type littermates (n=23). e and f, Camk2a-cre; miR-128-2fl/fl (n=8),
Camk2a-cre; miR-128-2wt/fl (n=21) and wild-type littermates (n=41).
Error bars show s.e.m.
* p<0.05; ** p<0.01; *** p<0.001, one-way ANOVA followed by Tukey's post test.
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Figure 9. Premature mortality is caused by an epileptic condition.

Figure 9. Premature is caused by an epileptic condition.
a, Depletion of miR-128-2 results in severe, spontaneous seizures. Daily
frequency of tonic-clonic seizures of a miR-128-2-/- (average 0.45 seizures per day)
and two Camk2a-cre; miR-128-2fl/fl mutants (average 0.77 and 0.54 seizures per
day) during the 22-day period preceding a recorded fatal seizure.
b, Mortality is rescued by administration of anti-convulsant valproate. KaplanMeier plot showing miR-128-2-/- mice (n=11) treated with sodium valproate from
weaning to 90 days of age (red line), compared to untreated mutants (black)
Percentage survival of miR-128-2-/- mutants at age 90 days: valproate
treated=90% ; untreated=8%. p<0.001 log-rank test.

42

Projection neuron specific deletion of miR-128-2 (Camk2a-cre; miR-128-2fl/fl)
produced a reduction of mature miR-128 levels in the adult brain identical to that
observed in miR-128-2 null mutants (Figure 6c,d). This suggests that previous
estimates of Camk2a-neuron miR-128 enrichment are likely to be an
underestimate. This is perhaps unsurprising given the likelihood of crosscontamination during the isolation process. Importantly, Camk2a-cre; miR-1282fl/fl mutants had identical reductions in lifespan and increases in basal locomotor
activity as null mutants (Figure 8d-f). These results suggest two important
conclusions: (i) the biological function of miR-128 relates to function of postdevelopmental mature neurons and (ii) miR-128 is uniquely important to
processes that occur in this neuronal subset.
To rule out the possibility that the effects demonstrated by the genetic
deletion of miR-128-2 might be caused by unintended perturbations of the host
gene (Arpp21) or neighboring genes, we crossed Camk2a-cre; miR-128-2fl/fl
mutants to transgenic animals that overexpress miR-128 so that miR-128-2
deletion and expression from the ROSA locus both occurred in Camk2a-neurons.
This genetic rescue experiment showed that miR-128 alone was sufficient to
normalize survival rates and locomotor activity (Figure 10).
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The relation between the concentration of miRNA in a cell and the
resultant effects on physiology are thought to depend on the expression profile
of its targets. In its role as a buffer against transcriptional noise, miRNAs
suppresses the translation of rare aberrant transcripts, in which case the cell
might be insensitive to relatively large changes in miRNA concentration above a
certain concentration at which all relevant target transcripts are bound. In its role
as a fine-tuner of transcript expression, moderate changes in miRNA
concentration might lead to similar changes in target transcript availability and
expression, and in turn that of cellular properties.
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Figure 10. Transgenic miR-128 expression rescues epilepsy and hyperactivity

Figure 10. Transgenic miR-128 expression rescues epilepsy and hyperactivity .
a, Expression of miR-128 from transgenic allele rescues epileptic mortality in
Camk2a deletion mutants. Kaplan-Meier survival plot for homozygous Camk2a
deletion mutants carrying no transgenic alleles (black, n=9, median lifespan 71
days), or one transgenic allele (light blue, n=11, median lifespan 129 days) or two
transgenic alleles (dark blue, n=4, median >200 days).
* p<0.05; *** p<0.001, log rank tests.
b, Expression of miR-128 from conditional transgenic allele normalizes
hyperlocomotion in Camk2a-cre; miR-128-2wt/fl heterozygous mutants. Total
horizontal distance traveled over 60 minutes in an open-field chamber by
heterozygous deletion mutants carrying either no transgenic allele (black, n=12),
or one transgenic allele (blue, n=15) and wild type controls (white, n=25).
Error bars show s.e.m. *** p<0.001, one-way ANOVA followed by Tukey's post
test.
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Basal locomotor activity was strongly dependent on the dosage of miR128. Heterozygous and homozygous deletion of miR-128-2 resulted in increasing
levels of hyperactivity in the open field. Conversely, heterozygous and
homozygous transgenic over-expression of miR-128-2 resulted in increasing
levels of hypo-activity compared to wild type controls (Figure 11b,c).
To further determine the dosage dependence of seizure susceptibility, we
examined the survival of mice with neuronal deletion of combinations of miR128-1 and miR-128-2. Different combinations of loci deletions correspond to
different levels of approximate miR-128 availability. The survival statistics
clearly show that decreasing levels of miR-128 are correlated with increased
mortality rates (Figure 12).
Finally, increased miR-128 endogenous levels suppressed the progression
of seizures induced by chemical convulsants. Seizures developed upon
imbalances in the ratio of excitatory to inhibitory tone. Increased excitatory tone
can be achieved using agonists of glutamatergic receptors e.g. kainic acid.
Correspondingly, suppression of inhibition can be achieved using GABA
receptor antagonists e.g. picrotoxin. The proportion of miR-128 overexpressing
mice that develop tonic-clonic seizures upon systemic administration of either
kainic acid or picrotoxin was lower than that of controls (Figure 11a). In
summary, loss and gain of miR-128 in Camk2a projection neurons of the adult
forebrain increases and suppresses seizure susceptibility and motor activity
respectively.
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Figure 11. Transgenic expression suppresses seizures and locomotion.

Figure 11. Transgenic expression suppresses seizures and locomotion.
a, Expression of miR-128 from transgenic allele suppresses chemical induction of
tonic-clonic seizures. Percentage of mice exhibiting tonic-clonic seizures upon
systemic injection of kainic acid or picrotoxin (n=12 per group). p-values
calculated by Fisher’s exact test.
b and c, Reduced motor activity upon miR-128 overexpression. b, Total
horizontal distance traveled and c, total rearing activity in an open-field over 60
minutes by double transgenic (black, n=21), single transgenic (gray, n=21) and
control mice (white, n=33).
Error bars show s.e.m. * p<0.05; ** p<0.01; *** p<0.001, one-way ANOVA
followed by Tukey's post test.
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Figure 12. Epileptic mortality is miR-128 dosage dependent.

Figure 12. Epileptic mortality is miR-128 dosage dependent.
a, Mating scheme for generation of postnatal neuron-specific double knock-out
of miR-128-1 and miR-128-2.
b, Kaplan-Meier plot, percentage of surviving animals as function of days after
birth is shown for listed mutants carrying combinations of miR-128-1 and miR128-2 alleles (sample number, median lifespan): Camk2a-cre; miR-128-1wt/wt; miR128-2wt/fl (n=26, >360 days), Camk2a-cre; miR-128-1wt/fl; miR-128-2wt/fl (n=16, 116
days), Camk2a-cre; miR-128-1wt/wt; miR-128-2fl/fl (n=25, 56 days), Camk2a-cre; miR128-1wt/fl; miR-128-2fl/fl (n=11, 38 days). All pairwise log-rank test p<0.005.
c, Line graphs summarize percentage animals surviving at 30, 40 or 50 days after
birth for each genotype. Approximate miR-128 levels for each genotype are
indicated.
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2.4 miR-128 expression in the striatum suppresses hyperlocomotion
Distance travelled during ambulatory activity is one example of a broad
set of normal motor activities, and serves as a reliable and consistent measure of
motor output as a whole. In the last few decades, large strides have been made
toward understanding the distinct neuronal subsets and networks that control
motor coordination, action selection or the magnitude of motor outputs. Some of
these studies have been undertaken to try to understand the range of motor
dysfunctions that afflict human patients such as Huntington’s disease or
Parkinson’s disease.
The striatum is the major input structure of the basal ganglia system and
has an important role in the control of motor output. Loss of dopaminergic tone
within this structure is the primary cause of akinesia in sufferers of Parkinson’s
disease.
To examine the relative contributions of striatal expression of miR-128 to
the regulation of basal activity, we generated mice with region-specific deletions
of miR-128-2. Adeno-associated virus expressing Cre-recombinase was injected
into the striatum of miR-128-2 floxed or wild type mice. Peak expression of Cre
recombinase occurs at around 20 days after injection. This experiment
demonstrates that miR-128-2 deletion in the striatum was sufficient to produce
increased baseline activity (Figure 13).
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Figure 13. Striatal deletion is sufficient to induce hyperactivity.

Figure 13. Striatal deletion is sufficient to induce hyperactivity.
a, Schematic of striatal deletion of miR-128-2 by bilateral stereotactic injection of
adeno-associated virus expressing Cre-recombinase (AAV-cre) into striatum of
either miR-128-2fl/fl or wild-type mice (left). miR-128 levels in striatum of miR-1282fl/fl mice injected with either AAV-Cre or vehicle were quantified by qRT-PCR
(n=3). * p<0.05, Welch's t-test.
b-c, Striatal deletion of miR128-2 was sufficient to induce basal hyperlocomotion.
b, Horizontal distance travelled in an open-field chamber in 10 minute intervals.
miR128-2fl/fl (n=14) or controls (n=8) stereotactically injected with AAV-Cre.
* p<0.05, 2-way repeated-measures analysis of variance (genotype).
c, Total horizontal distance traveled in an open-field chamber over 60 minutes.
* p<0.05, Welch's t-test. All error bars indicate S.E.M.
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2.5 Summary
Our work confirms the post-developmental restriction and forebrain
enrichment of miR-128. Our data also complements previous finding that miR128 is enriched in Camk2a-positive projection neurons by showing a strong
enrichment of miR-128 targets among the pool of Ago2 bound transcripts in
Camk2a-positive neurons of the adult forebrain. This CLIP-seq dataset allows us
to narrow down the list of possible physiological targets of miR-128 and these
targets suggest a role for miR-128 in the modulation of seizure and locomotion.
We addressed this hypothesis by deleting miR-128 both ubiquitously and
specifically in Camk2a-positive forebrain projection neurons. Depletion of miR128 in either case produced nearly identical, dose-dependent increases in
epileptic mortality and basal locomotor activity. These phenotypes are consistent
with a sensitive regulation of neuronal excitability by miR-128 in projection
neurons across the forebrain. In addition we show that miR-128 loss in the
striatum was sufficient to induce hyperactivity. In the next chapter we examine
miR-128 function in the striatum in detail.
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Chapter 3: miR-128 in medium spiny neurons of the striatum
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3.1 D1-MSNs and D2-MSNs: distinct projection neurons in the striatum
Camk2a-positive neurons in the striatum include two similarly sized
populations of DARPP-32-positive projection neurons called medium spiny
neurons (MSNs), which together account for over 90% of neurons in this
structure. Morphologically identical and anatomically intermingled, these
neurons also receive similar inputs from extra-striatal regions including
dopaminergic input from the midbrain and glutamatergic input from the
cerebral cortex and thalamus. However, these two populations project to
completely distinct output structures of the basal ganglia and participate in two
largely parallel circuits reviewed in (127). Furthermore, these two populations
are further differentiated by the unique expression of key proteins. Striatonigral
projecting MSNs (D1-MSNs) preferentially express Dopamine type 1 receptors
(Drd1), substance P and dynorphin. Striatopallidal projecting MSNs (D2-MSNs)
preferentially express Dopamine type 2 receptors (Drd2), Adenosine type 2
receptors (A2A) and enkephalin.
D1 and D2- MSNs exhibit a wide array of functional differences. They
display distinct dendritic excitability (128), engage distinct signaling outcomes in
response to dopamine (129, 130), employ distinct dopamine-dependent plasticity
mechanisms (131), and mediate distinct behavioral and learning outcomes upon
pharmacological and optogenetic stimulation (132-134). Furthermore, recent
expression studies identified hundreds of genes differentially expressed in the
two subtypes, expanding our understanding of known differences in signal
transduction and integration and revealing novel ones (135).

53

D1- and D2-MSNs of the striatum constitute a unique and fascinating
system to study divergent signaling architectures in similar neuronal
populations. Little is known about miRNA expression and function in MSNs, but
miR-128 is highly expressed in the striatum and we have shown that striatal
depletion alone can induce locomotor hyperactivity reminiscent of MSN
hyperstimulation. Furthermore, differences in signaling responses D1- and D2MSNs suggest different requirements of miR-128 activity. This is the hypothesis
we address in this chapter.
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3.2 Relative miR-128 expression in MSN populations
We first determined whether miR-128 is differentially expressed between
these two MSN populations. To this end, we generated mice expressing epitope
tagged-Ago2 in either D1 or D2 MSNs by breeding mice carrying the conditional
tagged-Ago2 allele with the respective Cre-driver lines. Tagged Ago2 was
immunoprecipitated from adult striatum tissue and total bound RNA was
isolated and the levels of most major murine miRNA families were quantified
using qRT-PCR on low-density arrays (Figure 14a). To correct for background
contamination by non-specific pull-down of miRNA, mice not expressing Cre
were used as controls, and processed in parallel.
Among all tested miRNAs, 184 were recovered at levels above nonspecific background. To compare expression levels between the two cell types, it
was necessary to normalize for the total isolated miRNA content of each
population. This was done in two ways: (1) using cycle count for miR-124, a
highly expressed neuronal miRNA induced early in neuronal differentiation and
(2) using the global mean cycle count for all miRNAs expressed above
background. Only miRNAs showing significant differences using both methods
were considered to be differentially expressed between D1 and D2-MSNs (Figure
14b). The analysis shows that 21 miRNAs were more highly expressed in D1
MSNs, including miR-128, and that 12 miRNAs were more highly expressed in
D2 MSNs. Real time PCR quantification was repeated and we confirmed that
miR-128 was expressed about two fold higher in D1 MSNs than D2 MSNs,
suggesting D1-MSNs make a greater contribution to the dysfunctions of miR-128
mutants (Figure 14c).
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Figure 14. Differential expression of miR-128 in D1 and D2 MSNs.

Figure 14. Differential expression of miR-128 in D1 and D2-MSNs.
a, Schematic summarizes generation of mice expressing flag-tagged Ago2 in
either D1- (green) or D2- (red) MSNs and cell-type specific isolation of Ago2associated miRNAs.
b, Left: miRNAs were quantified by qRT-PCR and normalized using cycle count
(Ct) of either the population median or miR-124a. Only the 33 miRNAs with
significant (p<0.05) differential expression in both cases were considered. Right:
Relative miRNA expression of selected miRNAs.
c, Left: Mating scheme to delete miR-128-2 in D1 or D2-MSNs in the striatum.
Right: miR-128 levels in adult striatum upon deletion in D1- or D2- MSNs.
All error bars indicate S.E.M. *** p<0.001 ** p<0.01, * p<0.05, Welch's t-test.
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3.3 miR-128 has a unique role in D1-MSNs
To test whether D1-MSNs provide a greater contribution to the observed
hyperlocomotion and seizures, we generated mice with deletion of miR-128-2 in
either D1- or D2-MSNs (hereafter Drd1a-cre; miR-128-2fl/fl and A2a-cre; miR-1282fl/fl respectively). To help quantify the non-striatal contribution to hyperactivity,
we also generated mutants in which miR-128-2 was deleted in all neuronal
populations of the hippocampus and cortex (Emx-cre; miR-128-2fl/fl). These
subtype-specific deletions exhibited interesting differences of phenotype.
Reductions in pan-striatal miR-128 levels upon deletion in D1-MSNs were
greater than that upon deletion in D2-MSNs, supporting our previous
observation that miR-128 was comparatively enriched in D1-MSNs (Figure 14c).
In the open-field assay, Drd1a-cre; miR-128-2fl/fl mutants displayed a strong
hyperactivity compared to controls similar to that observed with Camk2a-cre;
miR-128-2fl/fl mutants (Figure 15a-c). Like Camk2a-cre; miR-128-2fl/fl mutants, the
increased locomotor activity of Drd1a-cre; miR-128-2fl/fl mutants was not
accompanied by increased thigmotaxis (the tendency of mice to conduct most of
their exploratory behavior at the periphery of the chamber due to the presence of
tactile responses to chamber walls). Other measures of behavioral anxiety using
elevated plus maze and light-dark chamber also confirmed that hyperlocomotion
was not accompanied by increased anxiety (data not shown). In contrast, A2a-cre;
miR-128-2fl/fl mutants showed no difference in locomotor activity compared to
wild-type littermates (Figure 15d-f).
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Figure 15. miR-128 deletion in D1 but not D2 MSNs results in hyperactivity.

Figure 15. miR-128 deletion in D1 but not D2 MSNs results in hyperactivity.
Open field activity of Drd1a-cre; miR-128-2fl/fl mutants (a-c), A2a-cre; miR-128-2fl/fl
mutants (d-f), and Emx-cre; miR-128-2fl/fl mutants (g-i).
a, d, g, Horizontal activity in 10 min intervals. b, e, h, Total horizontal activity
over 60 mins. c, f, i, Total rearing activity over 60 mins.
All error bars indicate S.E.M. *** p<0.001 ** p<0.01, * p<0.05, Welch's t-test.
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Emx-cre; miR-128-2fl/fl mutants displayed a milder locomotor phenotype
that was also qualitatively different from that of Drd1a-cre; miR-128-2fl/fl mutants
(Figure 15g-i). These mutants showed the greatest activity difference occurs in
the initial period of exposure to the open field chamber and this activity
difference progressively narrowed over time. Two-factor (time and genotype)
analysis of variance (ANOVA) showed a clear dependence on both and a
significant interaction between the two factors. In contrast, Drd1a-cre; miR-1282fl/fl mutants showed identical activity increase over controls throughout the 60
minutes in the open field chamber. Two-way ANOVA showed a lack of
dependence on time interval and no interaction between time interval and
genotype. This suggests that while miR-128 deletion in D1-MSNs produces
constant elevated activity, deletion in the cortex and hippocampus results in
higher novelty-induced locomotion, which diminishes over time. The severe
phenotype seen in Camk2a-cre; miR-128-2fl/fl mutants is likely to result from a
combination of these two aspects.
Finally, Drd1a-cre; miR-128-2fl/fl mutants displayed spontaneous home
cage seizures resulting in increased mortality although not as severe as that
observed in Camk2a-cre; miR-128-2fl/fl mutants, with a median lifespan of 142 days
(Figure 16a) In contrast, A2a-cre; miR-128-2fl/fl mutants showed no increase in
mortality over littermates and all mutants survived over a year (Figure 16b).
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The rate of epileptic mortality was even greater in Emx-cre; miR-128-2fl/fl
mutants, with a lower median lifespan of 105 days, consistent with a known role
of the hippocampus in promoting seizure generalizations (Figure 16c).
Interestingly, using the inverse of the median lifespan to approximate the rate of
death of each mutant line (rate = 1/(median lifespan)), a simple addition of the
death rates of Emx-cre; miR-128-2fl/fl and Drd1a-cre; miR-128-2fl/fl mutants very
closely approximates the death rate of Camk2a-cre; miR-128-2fl/fl mutants.
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Figure 16. miR-128 deletion in D1 but not D2 MSNs results in fatal epilepsy.

Figure 16. miR-128 deletion in D1 but not D2 MSNs results in fatal epilepsy.
Kaplan-Meier survival plots for: a, Drd1a-cre; miR-128-2fl/fl mutants (green, n=16)
and controls (grey, n=39); b, A2a-cre; miR-128-2fl/fl mutants (red, n=8) and
controls (grey, n=8) and c, Emx-cre; miR-128-2fl/fl mutants (brown, n=19) and
controls (grey, n=54). a, c, p<0.001 log rank tests. All A2a-cre; miR-128-2fl/fl
mutants survived for a year until they were sacrificed.
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3.4 Summary
Behavioral changes resulting from deletion of miR-128 in D1-MSNs but
not D2-MSNs was sufficient to recapitulate the phenotypes observed in Camk2acre; miR-128-2fl/fl mutants, suggesting a unique role of miR-128 in regulating the
properties of D1-MSNs. The cortical-hippocampal contribution to seizure
susceptibility is larger but we show that loss of miR-128 in D1-MSNs is necessary
and sufficient for a novelty-independent baseline increase in motor activity and
fatal epilepsy.
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Chapter 4: miR-128 targets and MAPK pathway

63

4.1 Ribosomal profiling in D1-MSNs reveals regulated targets
The primary effect of miRNA expression is the translational suppression
and/or degradation of specific target mRNA transcripts. Most, if not all, of the
biological consequences of miRNA expression stems from this repression of
target transcripts. To understand how miR-128 depletion results in the
behavioral and cellular dysfunction demonstrated so far, we need to identify
physiological targets of miR-128.
We have shown that D1-MSNs contain most of the striatum-expressed
miR-128 and that D1 specific deletion of miR-128 results in hyperactivity and
seizure. To determine target genes dysregulated in D1-MSNs in the absence of
miR-128, we made use of a ribosomal profiling strategy-TRAP (135) that allows
the comprehensive quantification of mRNA levels in a specific population of
cells. By crossing our Drd1a-cre; miR-128-2fl/fl mutants with transgenic mice
expressing tagged ribosomal subunits in D1-MSNs, we generated animals in
which D1 neurons are miR-128 deficient and express tagged ribosomes. Briefly,
Drd1a-cre; miR-128-2fl/fl mutants carrying tagged ribosomes in D1-MSNs were
used for polysome immunoprecipitation and polysome-associated transcripts
were analyzed by microarray. Control mice carrying tagged ribosomes but
negative for Cre recombinase were used for comparison. Two independent
experiments were performed involving 8 controls and 9 mutants. Using a nonconservative analysis, over 2000 probes showed significantly different expression
levels in the absence of miR-128 ( p<0.05, two-way ANOVA for genotype)
(Figure 17a).
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As typical expression changes of target genes in response to miRNAs are
very small (<1.5 fold), and could involve an unknown number of primary
targets, we chose a non-conservative significance cutoff and no minimum cutoff
for fold change. While this means that most of the primary targets of miR-128 are
likely to be included in this list, it would also include secondary expression
changes and a significant number of false positives. To test if the expression
changes detected include changes in primary target genes, we looked at
differences in mean derepression levels of various sub-populations:
Firstly, genes with one or more miR-128 6-mer seed sites within their
annotated full-length Refseq transcripts had much greater levels of derepression
compared with genes that contained no sites. Furthermore, Ago-associated genes
containing miR-128 seeds within isolated clusters (CLIP-seq) showed even higher
levels of derepression (Figure 17b).
Secondly, among CLIP-seq positive genes, those in which miR-128 seedcontaining clusters occurred in the 3’UTR were more derepressed than those in
which such clusters occurred in the coding region (Figure 17b). This is in line
with some previous findings that most functional interactions between miRNA
and its target occur in the 3’UTR (50, 51)
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Figure 17. Ribosomal expression profiling in D1-MSNs.
a, Schematic summarizes D1-MSN specific ribosomal profiling. Mice with D1MSN specific deletion of miR128-2 and transgenic expression of tagged ribosomal
subunit. Total striatum was dissected from mutant (Drd1a-cre; miR128-2fl/fl; Drd1aeGFP-L10a) and control (miR128-2fl/fl; Drd1a-eGFP-L10a) littermates. Polysome
associated mRNA transcripts were isolated and profiled from 2 independent
experiments by microarray (7-8 mice per group total). Green ribosomes: eGFPtagged ribosome; black ribosomes: untagged ribosomes.
b-c, Ago-bound CLIP-seq miR-128 targets are preferentially upregulated.
b, Mean log fold changes of all differentially expressed genes (All); genes with
either 0 or ≥1 miR-128 6mer target site in its full annotated sequence (No 6mer
and Refseq 6mer); and genes with 6mer-containing CLIP-seq cluster anywhere,
in 3'UTR only, or in coding regions only (CLIP-seq 6mer, CLIP-seq 6mer 3'UTR,
CLIP-seq 6mer ORF). Number of probes indicated in brackets.
c, Mean log fold changes of all differentially expressed genes (All), CLIP-seq
targets of miR-128 and that of other miRNAs. CLIP-seq targets are genes with a
CLIP-seq cluster in the 3'UTR that contains 6mer target site(s) for a given
miRNA.
d, Venn diagram illustrates definition of primary target genes as miR128 CLIPseq targets that are differentially expressed in the absence of miR128 as shown by
ribosomal profiling.
** p<0.01, *** p<0.001, one-way ANOVA followed by Dunnett’s post test against
group of all differentially expressed genes (All). All error bars indicate s.e.m.
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Figure 17. Ribosomal expression profiling in D1-MSNs.
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4.2 Primary target genes
Based on the above results, we restricted the list of primary targets genes
(PTGs) to those which fulfilled the following conditions:
1. Association with Ago2 in neurons as shown by the presence of 3’UTR CLIPseq cluster(s) containing at least one miR-128 6mer seed.
2. Significant expression change in the absence of miR-128 as assayed by
ribosomal profiling in D1-MSNs.
In further validation of our stringent criteria, we compared the mean derepression of miR-128 primary targets with that of other miRNAs using the same
criteria (presence of miRNA seed site within Ago CLIP-seq cluster in the 3’UTR)
and with the entire population of altered genes as a whole. Primary miR-128
targets (and not that of other miRNAs expressed in Camk2a neurons) were
significantly more de-repressed than the set of all altered genes (Figure 17c). This
confirms the utility of using CLIP-seq data to isolate actual targets from the large
population of genes with altered expression.
Applying the above criteria narrowed our search to 104 upregulated PTGs
(131 probes). For comparison purposes, there are significantly fewer
downregulated genes (40 unique genes, 47 probes) fulfilling our criteria (Figure
17d). As miRNAs are solely thought to repress targets, the presence of this
smaller but significant group of downregulated PTGs was taken to indicate the
false positive rate of our analysis. For now, both groups are included in our
analysis although we will address this issue below.
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To confirm that most if not all of upregulated primary targets were bona
fide miR-128 targets, full-length 3’UTRs of 10 randomly selected targets were
cloned downstream of a firefly luciferase gene and expressed in cultured
Neuro2A cells. Responsiveness to exogenous miR-128 mimics co-transfected
with the reporter plasmid could be assayed by luciferase activity. All tested
targets showed significant repression by miR-128 mimic compared to scramble
control mimic, while none of the negative controls showed significant responses
(Figure 18b).
The level of derepression was mild, ranging for 1.2-fold to just over 2-fold
increase in the absence of miR-128 (Figure 18a). This is in line with most previous
studies examining the level of repression by miRNAs (58). Quantification of
selected proteins by Western blot analysis indicated that repression of protein
levels was only slightly higher than that observed with ribosomal profiling
(Figure 18c).
The use of ribosomal profiling confers many advantages over expression
studies using total RNA samples extracted from dissected tissue. Firstly, genetic
targeting allows cell-specific isolation of transcripts. Therefore, expression
changes are not diluted by the presence of transcripts from non-miR-128
expressing cells (glia, interneurons), or cells in which miR-128 expression is
lower and might lead to smaller repression rates (D2-MSNs). This is especially
significant if targets are also relatively depleted within the target cell type.
Secondly, miRNAs affect the recruitment and translation of transcripts by
ribosomes, with mRNA degradation occurring subsequently in most but not all
cases. Ribosomal profiling thus provides a more accurate picture of expression
changes compared to mRNA quantification alone.
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Figure 18. Primary target genes.
a,

Heat map of upregulated primary target genes showing fold changes in

ribosomal association in D1-MSNs. Genes are listed in descending order of
average fold change over control samples. Columns show each of two
experimental repeats.
b, In-vitro confirmation of primary targets. Luciferase reporters carrying full
3'UTR sequences of a subset of primary target genes were tested for responsivity
to either scrambled control or miR-128 mimics in Neuro2A culture. Mean
normalized luciferase activity for each reporter is expressed relative to that in the
presence of control mimic. RCS and BDNF constructs are included as negative
controls. All tested primary target reporters showed significant responses to
miR128 mimics. * p<0.05; ** p<0.01; *** p<0.001, Welch's t-test.
c, Mean protein level changes in the striatum were quantified for 3 primary
targets D4ertd22e (left), Pea15a (middle) and Tarpp/Arpp21 (right). Bar graphs
show mean expression levels quantified from dissected striata (n=4 each) by
Western blot, normalized to actin loading controls and expressed relative to
mean control expression. Representative blots for each target are shown above
respective bar graph. * p<0.05; ** p<0.01, Welch's t-test.
All error bars indicate S.E.M.
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Figure 18. Primary target genes.
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To illustrate the advantages of this method, we made use of the Camk2acre; miR-128-2fl/fl mutants described in Chapter 2. Total RNA was extracted from
dissected striata of both mutants and their respective controls and mRNA
expression quantified by microarray. We compared mean fold changes of the 178
miR-128 PTGs obtained from D1-MSN ribosomal profiling experiments to those
obtained from analyzing total striatal RNA from Camk2a-cre; miR-128-2fl/fl
mutants. Previous work using ribosomal profiling to quantify target expression
changes have shown that for the majority of targets, changes in ribosome
association is accompanied by reductions in target mRNA (79).
The observed fold changes were significantly higher using ribosomal
profiling as expected for the reasons listed above. In spite of this, we were able to
detect mild derepression of nearly all the upregulated PTGs, and a very
significant derepression of the population as a whole, suggesting that we could
use microarray assays of total RNA to examine other properties of the PTGs.
We have shown earlier that miR-128 exerts a bidirectional control of both
locomotor activity as well as seizure susceptibility. It is therefore likely that the
primary targets of miR-128 should exhibit similar bidirectional dynamics. To test
this, we made use of the Camk2a-cre; miR-128-2fl/fl deletion mutants and Camk2acre; ROSAmiR-128/miR-128 overexpression mutants described in Chapter 2. Total RNA
was extracted from the striata of both mutants and their respective controls and
quantified by microarray. Up-regulated PTGs showed highly significant
bidirectionality - up-regulated in deletion and repressed in overexpressing
mutants (p<10^9). In contrast the 47 downregulated primary targets did not
show bidirectionality (p>0.05), confirming our previous view that these genes
were not primary targets (Figure 19a,b).
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To test if PTGs were similarly targeted in other brain regions, we dissected
cortical, hippocampal and striatal samples from Camk2a-cre; miR-128-2fl/fl mutants
and analyzed total RNA as above. Each PTG was marked as either up-regulated
or down-regulated for each brain region. For example, a particular subset of the
upregulated PTGs would be seen upregulated in the cortex, while a different
subset might be upregulated in the hippocampus. 25 genes were not upregulated
in any region, consistent with the lower resolution using total RNA. Of the
remaining genes, we found a very significant overlap of upregulated genes
across all 3 regions, suggesting a broad conservation of miR-128-target pairings
in multiple cell types (Figure 19c,d).
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Figure 19. Upregulated PTGs are bidirectionally regulated and shared across
brain regions.
Upregulated (a,c) and downregulated PTGs (b,d) are assessed for co-regulation
across brain regions (a,b) and for bidirectionality (c,d).
a, b, mRNA from hippocampus, striatum and cortex of Camk2a-cre; miR-128-2fl/fl
mutants were quantified by microarray. a, Upregulated PTGs were assessed if
they were upregulated over control samples in each region and numbers were
represented in Venn diagram. p<0.001 for all 3-way and 2-way interactions, loglinear analysis. b, Downregulated PTGs were assessed if they were
downregulated over control samples in each region and similar represented.
p>0.05 for all interactions, log-linear analysis.
c, d, mRNA from striatum of deletion mutants (grey, Camk2a-cre; miR-128-2fl/fl )
and transgenic overexpression mutants (blue, Camk2a-cre; ROSAmiR-128/miR-128) were
quantified by microarray. Mean log fold changes of upregulated PTGs (c) and
downregulated PTGs (d) are shown. p-values calculated by paired t-test.
All error bars indicate S.E.M.
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Figure 19. Upregulated PTGs are bidirectionally regulated and shared across brain regions.

75

4.3 Convergent modulation of ERK pathway by miR-128 targets
The relation between miRNA targets and the apparent biological function
of a miRNA is necessarily a complex one. Many studies have focused on the role
of single or few targets often selected from predicted target lists based on the
presence of miRNA seed sites. While such strategies are useful in explaining
narrowly defined effects of miRNA perturbation, they can only partially account
for broader phenotypic outcomes. A fuller accounting for miRNA effects might
require examining the consequences of repression of all real target genes, but it is
often difficult to see how large groups of genes might interact.
To assess if these genes converge upon common biochemical networks or
pathways, we used literature curated analysis programs to look for enrichment
of known pathways and networks among these genes. Ingenuity network
analysis predicts gene networks from a given set of genes using known and
predicted biochemical interactions, enabling diverse genes to “merge” around a
few common interactions. Such an analysis produced a top ranked network in
which many of the miR-128 targets we identified converge on MAP kinaseERK1/2 proteins (Figure 20). The MAP kinase-ERK pathway was also among the
two pathways showing significant enrichment with our primary target gene list
using KEGG pathway annotations (Figure 20). These findings were surprising as
many of these interactions were predicted or poorly studied. Closer examination
of links between targets and the ERK signaling pathway might reveal further
possible interactions.
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Figure 20. Primary targets are enriched for genes that modulate the ERK signaling pathway.

Figure 20. Primary targets are enriched for genes that modulate the ERK
signaling pathway.
Above: Top ranked network cluster from Ingenuity Network analysis of all
upregulated PTGs. Below: KEGG pathway analysis of upregulated PTGs
showing significantly enriched pathways.
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To test if phosphorylation levels of ERK or other signaling pathways were
altered in the absence of miR-128, we measured levels of total and
phosphorylated signaling intermediates and kinases using enzyme-linked
immunosorbent assay (ELISA). Among these, only levels of phosphorylated ERK
were significantly elevated in Drd1a-cre; miR128-2fl/fl mutant striata (Figure 21a).
Relating absorbance readings to serial dilutions of control samples suggested
that mutant samples contained approximately 1.6-fold higher concentration of
phospho-ERK than controls (Figure 21b). No other assayed phospho-proteins
(including, JNK/SAPK and AKT kinase) were altered, demonstrating a specific
effect on ERK pathway activation.
Western

blot

quantification

using

similarly

processed

samples

demonstrated a 1.6-fold increase in phosphorylation levels of ERK2/P42 (Figure
21c), with no increase in ERK1/P44 phosphorylation (data not shown). We found
no change in the baseline phosphorylation levels of DARPP-32 Thr34 suggesting
that that is no increase in levels of dopamine or dopamine receptors or no
enhanced dopamine receptor activation (data not shown). Similar quantification
of phospho-ERK from striata of neuronal deletion and overexpression miR-128
mutants showed that this phenomena was also bidirectionally regulated by miR128, consistent with the bidirectionality seen both in the phenotypes of these
mutants and in the expression of primary targets genes (Figure 21d,e).
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Figure 21. ERK signaling is enhanced in the absence of miR-128.

Figure 21. ERK signaling enhanced in the absence of miR128.
a, Increased activation of ERK but not other kinases in Drd1a-cre; miR-128-2fl/fl
mutants (n=4). Levels of phosphorylated species of kinases indicated were
quantified from striatal samples by ELISA.
b, ELISA titration curve using combined control samples show that mutant
phosphoErk levels are increased 1.65 fold over control. * p<0.05, Welch's t-test.
c-e, Levels of P42 and phosphorylated P42 were quantified by western blot from
striatal samples, phosP42 levels were normalized to total P42 levels, P42 levels
were normalized to "-actin loading controls, and all values expressed relative to
control mean. Increased P42 phosphorylation in Drd1a-cre; miR-128-2fl/fl mutants
(c), and Camk2a-cre; miR-128-2fl/fl mutants (d). Decreased P42 phophorylation in
Camk2a-cre;

ROSAmiR-128/miR-128

transgenics

overexpressing

miR-128

Represenative blots are shown. (n=4 each). * p<0.05. ** p<0.01, Welch's t-test.
All error bars indicate S.E.M.
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(e).

4.4 Summary
The demonstration of the strong functional significance of miR-128 in D1MSNs (previous chapter) presents a relatively homogeneous neuronal
population in which to isolate miR-128 targets. We have made use of different
approaches to identify the physiologically relevant targets of miR-128 in vivo
that exhibit the following properties: (i) 3’UTR association with Ago2 in neurons;
(ii) presence of miR-128 seed within region of Ago2 association; (iii) significant
derepression in the absence of miR-128; (iv) bidirectionality of regulation by
miR-128; (v) regulation by miR-128 in multiple regions of the forebrain. The list
of primary target genes we identified suggested a role for miR-128 in the
regulation of ERK-mediated pathways. In agreement with this, we showed that
uniquely among kinase-mediated signaling pathways, activation of the ERK2
was sensitively controlled by miR-128. Control of ERK2 by miR-128 is consistent
with the effect of miR-128 on behavioral excitation. We will examine the possible
physiological effects of ERK regulation and its contribution to hyperlocomotion
in the next chapter.
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Chapter 5: Control of ERK activation by miR-128 in D1-MSNs
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5.1 ERK signaling in D1-MSNs
Extracellular signal-regulated kinases 1 and 2 (ERK1/2) are members of a
broader family of serine/threonine kinases known as the mitogen-activated
protein kinases (MAPK), and arguably the best characterized (reviewed in (136)).
Like all MAP kinases, ERK1/2 are activated by a series of upstream kinases that
transduce and amplify an initial extracellular or intracellular event. Upstream
kinases have high substrate specificity, phosphorylating only a restricted subset
of MAP kinases. In the case of ERK1/2, MAP/ERK kinases 1/2 (Mek1/2) are the
unique upstream activating kinases.
ERK1 (P44) and ERK2 (P42) are nearly identical (85% sequence similarity)
and universally expressed. However, some important functional differences
exist. While ERK1-deficient mice display only subtle phenotypic effects (137),
ERK2 deficiency is embryonic lethal (138). In the adult brain, basal
phosphorylation and glutamate induced phosphorylation of ERK2 is much
stronger than ERK1 (139). Furthermore, ERK1 deletion does not appear to affect
learning ability (140), but mild reductions in ERK2 levels impairs long term
memory (141).
Previous studies showed that the elevation in basal activation of ERK2
upon miR-128 depletion is consistent with the epilepsy and hyperlocomotion
phenotypes we observed. Postnatal expression of a constitutively active MEK1 in
projection neurons resulted in higher phospho-ERK levels and caused
spontaneous and severe seizures (142). In addition, mice with constitutive ERK1
deletion show enhanced ERK2 signaling in the striatum and cortex, and
increased basal horizontal and vertical activity in the open field (139).
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The drugs of abuse cocaine and amphetamine strongly induce ERK2
phosphorylation in the striatum. Induction of ERK2 phosphorylation occurs
almost exclusively in D1-MSNs and requires activation of both Dopamine D1
receptors and NMDA glutamate receptors (130, 143). Therefore, ERK2
phosphorylation mediates detection of coincident dopamine and glutamate
inputs within D1-MSNs.
A number of studies contributed to our current understanding of
coincident detection (132, 143-145). D1 activation results in phosphorylation of
Thr34 on DARPP-32 by PKA, which in turn inhibits protein phosphatase 1 (PP1).
PP1 inhibits STEP, which dephosphorylates ERK (143). D1 receptor activation
therefore

promotes

ERK

activation

by

suppressing

dephosphorylation.

Glutamate activation of ERK is less well understood but it is thought to require
calcium entry via NMDA receptors and Ras-GRF1 (144, 145).
ERK2 activation initiates a cascade of phosphorylation events in the
cytoplasm and nucleus to promote synaptic plasticity and transcriptional
adaptations that accompany cocaine stimulation. Pre-treatment with MEK1
inhibitor SL327 at high dose inhibits the locomotor response to acute cocaine
(146). In addition, paired pre-treatment with SL327 prior to cocaine
administration abolishes locomotor sensitization (147). These results suggest a
role for ERK in the regulation of basal excitability as well as the persistent
changes that result from it.
Both high-frequency afferent stimulation and cocaine administration
induce ERK-dependent long-term potentiation (LTP) in D1-MSNs (148). The
specific mechanisms that transduce ERK activation into dendritic and synaptic
potentiation in MSNs are still unclear but are thought to be similar to those that
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occur in hippocampal neurons. ERK phosphorylation inactivates Kv4.2
potassium channels (149), which regulate MSN dendritic, and spine excitability
(128). ERK activity also promotes AMPA receptor insertion at synapses (150,
151), and increases dendritic branching and spine density in MSNs (152). The
significance of these mechanisms was demonstrated in a recent study in which
optogenetic depotentiation of cocaine-potentiated synapses in D1-MSNs was
sufficient to reverse the expression of locomotor sensitization (148).
In the D1-MSN nucleus, cocaine-induced ERK activity promotes
phosphorylation

of

MSK1.

MSK1

activation

in

turn

activates

CREB

phosphorylation at Ser133 and Histone H3 phosphorylation at Ser10, to induce
immediate early genes (130, 153). This ERK-dependent transcriptional response
is an important component of long-term behavioral adaptations, as MSK1
deficient animals display reduced locomotor sensitization upon repeated cocaine
administration (153).
Aside from these plasticity mechanisms, the regulation of ERK pathway in
D1-MSNs is also an important component in the pathology of Parkinson's
disease (PD). In Parkinson's disease, death of midbrain dopamine neurons
results in loss of dopaminergic tone in the striatum, silencing of D1-MSNs and
progressive akinesia (154). The study of Parkinson's disease has been greatly
aided by the use of animal models of Parkinsonian-like dopamine depletion. One
widely used murine model involves the stereotactic injection of the dopamine
derivative 6-hydroxydopamine (6-OHDA) into the striatum, where it is taken up
at dopamine releasing terminals by the dopamine re-uptake mechanism. Uptake
into cells results in apoptotic death and destruction of nigrostriatal input (155).
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One well-known epiphenomenon of dopamine depletion is dopamine
supersensitivity (156), which takes the form of exaggerated behavioral and
signaling responses to dopamine agonists such as L-dopa. Dopamine
supersensitivity occurs in response to D1 agonists but not D2 agonists, and
results in supersensitive activation of ERK and its downstream targets in D1MSNs (157). The induction of ERK activation by D1 receptor agonists is very
mild in normal mice. The requirement for contemporaneous dopamine and
glutamate inputs to induce ERK phosphorylation might explain this restricted
response. In the dopamine-depleted striatum however, most D1-MSNs become
phospho-ERK positive upon stimulation by similar doses of agonist (158).
L-dopa induced dyskinesia (LID) is a common and early-noted side effect
of treating PD with L-dopa (159), which involves a range of abnormal
involuntary movements which include orofacial and limb dyskinesias. LID has
been successfully modeled in rat and mouse by chronic L-dopa administration in
6-OHDA lesioned animals. D1-MSN supersensitivity shares many mechanistic
similarities with LID. Both acute and chronic administrations of L-dopa in
lesioned animals induce abnormal activation of the ERK pathway in D1-MSNs
(158, 160). Furthermore, pharmacological inhibition of ERK during chronic Ldopa treatment reduces LID (158).
The ERK pathway mediates several physiological and pathological
processes in D1-MSNs. miR-128 regulates steady state ERK activation in D1MSNs. In this chapter, we will explore the biological effects of this regulation.
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5.2 miR-128 suppresses basal electrophysiological excitability of D1-MSNs
MAPK activation can result in changes in intrinsic excitability. ERK
phosphorylation inactivates dendritic potassium channel Kv4.2, changes AMPA
cycling kinetics to favor increased AMPA receptor insertion and promotes spine
formation. To examine electrophysiological changes in D1-MSNs in the absence
of miR-128, we collaborated with Dr. Josh Plotkin at Northwestern University. In
order to interrogate D1-MSNs specifically we made use of Drd1a-cre; miR128-2fl/fl
mutant mice expressing eGFP-tagged L10a ribosomal subunit in D1 MSNs (D1eGFP-L10a). The eGFP-tagged ribosomes produce a robust green fluorescent
signal in the nucleolus, allowing for easy identification by fluorescence
microscopy. Mutant D1-MSNs showed greater dendritic excitability, potentiated
synaptic AMPA response and increased density of distal spines, consistent with
the cocaine-induced ERK-dependent effects previously described (Figure 22).
Dendritic membrane excitability is measured by the decrease in backpropagating action potential (bAP) amplitude in distal dendrites compared to
proximal dendrites upon current injection at the soma. Dendritic membrane
excitability is believed to be regulated by Kv4.2 voltage-activated K+ channels in
cortical, hippocampal and striatal neurons. It is also known that Kv4.2 channels
are inactivated by ERK phosphorylation. Furthermore, Mek inhibition of basal
phospho-ERK also reduces basal phosphorylation of Kv4.2 and decreases distal
dendrite bAP amplitude. Therefore, our finding of heightened distal dendritic
membrane excitability is fully consistent with the increased basal phospho-ERK
levels.
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Figure 22. miR-128 suppresses intrinsic excitability of D1-MSNs.
a, Dendritic excitability is enhanced in D1-MSNs in Drd1a-cre; miR128-2fl/fl; Drd1aeGFP-L10a mutants. Single action potentials were generated in the soma by
injecting positive current through the electrode. The evoked calcium transients
were measured in proximal (~50 µm from soma) and distal (~100-120 µm from
soma) dendritic shafts by performing synchronized line scans. The attenuation of
the bAP signal along the dendrite was calculated by dividing the distal calcium
signal by the maximum proximal calcium signal per cell.

Attenuation was

significantly enhanced in mutant dendritic shafts. n=4 cells, 11-21 shafts per
group.
b, Synaptic excitability is enhanced. Miniature excitatory post-synaptic currents
(mEPSCs) were recorded by whole-cell patch recording on control and mutant
D1-MSNs.
c, Spine density is increased. Left: Maximum intensity projection (MIP) images
of distal (~100 µm from soma) dendrites in control and mutant D1-MSNs. Right:
Box plots showing population spine densities. n=10-11 cells per group.
d-e, Somatic excitability is unaltered. d, Example responses of a wild type (top)
and mutant (bottom) D1-MSN to somatic current injections. Voltage traces are in
response to -100, -50, +100, +190 and +250 pA. e, Frequency-current (F-I) plot
showing average firing frequencies to somatic current injection. No difference
was observed between WT (N=6) and KO (N=7) dSPNs (Mann-Whitney
nonparametric test, p>0.05).
* p<0.05, *** p<0.001, Mann-Whitney nonparametric test.
Data and figures courtesy of Josh Plotkin.
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Figure 22. miR-128 suppresses intrinsic excitability of D1-MSNs
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5.3 ERK inhibition reverses hyperlocomotion in Drd1a-cre; miR128-2fl/fl
mutants
Cocaine-induced synaptic potentiation in D1-MSN is one major cause of
locomotor sensitization. Similarly, the increased excitation profile of the miR-128
depleted D1-MSN might be a likely cause of basal hyperlocomotion of Drd1a-cre;
miR128-2fl/fl mutants. In this model, mutant D1-MSNs have greater firing
propensity in response to unchanged endogenous input. If chronic ERK2
activation is a cause of higher excitability of D1-MSNs, then ERK inhibition
might be sufficient to normalize basal hyperlocomotion.
Systemic administration of SL327 (a blood-brain barrier crossing
derivative of U0126, a MEK1 inhibitor) resulted in inhibition of locomotion in the
open field chamber. We examined the distance traveled in the open field by
mutants and control mice after injection of increasing doses SL327 and found
that mutants responded more strongly to SL327 inhibition. At a dose of
12.5mg/kg, SL327 inhibited activity of mutants with no significant effect on
controls. To confirm this finding, the experiment was repeated with a second
cohort of mice. In this experiment, mutants and controls were injected with either
vehicle (DMSO/Saline) or a 12.5mg/kg dose of SL327. The results clearly show
that at this low dose, mutant and control locomotion was equalized with no
change in the activity of control mice (Figure 23b). The experiment was repeated
and phospho-ERK levels were quantified 30 minutes post-injection, showing that
baseline ERK activation was also normalized at this dose (Figure 23a).
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As SL327 injection resulted in broad inhibition of MEK1, we further tested
the causative role of ERK in mutant hyperlocomotion using genetic means by
making use of a previously generated transgenic mouse line with Cre dependent
expression of dominant negative MEK1 (dnMEK). The dominant negative MEK1
protein contains a lysine to methionine substitution within the ATP binding site,
eliminating its kinase activity but preserving the ability to bind ERK1/2.
The protein is expressed downstream of a chicken beta-actin promoter
region and a floxed STOP-cassette, which permits recombinase control of
expression. We crossed dnMEK transgenic animals with Drd1a-cre; miR128-2fl/fl
mutants to generate mice in which heterozygous miR-128-2 deletion and dnMEK
expression occur in D1-MSNs. Total activity in the open field was lower in
mutants expressing dnMEK, and did not significantly differ from that of wild
type control mice (Figure 23c).
In conclusion, using pharmacological and genetic means of MEK1
inhibition, we have tested and shown that increased ERK activation had a
causative role for the hyperactivity observed in the mutant animals in which
miR-128 was depleted in D1-MSNs.
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Figure 23. miR-128 modulates motor activity via ERK activation in D1-MSNs.
a, Increased Erk2 phosphorylation is normalized by low dose Mek inhibitor.
Drd1a-cre; miR-128-2fl/fl or controls were injected with either vehicle or 12.5mg/kg
SL327 (n=5) and striata were dissected 30 min later. Right: Phosphorylated P42
levels were quantified by Western blot, normalized to total P42 levels and
expressed relative to mean control levels. Left: Representative blot is shown.
* p<0.05, ** p<0.01, 2-way ANOVA followed by Bonferroni post test.
b, Basal hyperlocomotion is normalized by pharmacological Erk inhibition. Left:
Horizontal distance travelled in an open-field chamber in 10 minute intervals.
Drd1a-cre; miR128-2fl/fl mutants and littermate controls were injected with either
vehicle or 12.5mg/kg SL327 prior to measurement. (n=16 each group). ** p<0.01,
two-way repeated measures ANOVA (treatment). Right: Total horizontal
distance travelled in an open-field chamber over 60 minutes. *** p<0.001, 2-way
ANOVA followed by Bonferroni post test.
c, Genetic suppression of Erk2 phosphorylation using conditional transgenic
dominant negative MEK1 (dnMEK1) rescues basal hyperactivity in Drd1a-cre;
miR128-2wt/fl heterozygous mutants. Left: Horizontal distance travelled in an
open-field chamber in 10 minute intervals. Drd1a-cre; miR128-2wt/fl heterozygous
deletion mutants carrying one transgenic dnMEK1 allele (Drd1a-cre; miR-128-2
dnMEK1+, n=11), mutants carrying no transgenic alleles (Drd1a-cre; miR-128-2

wt/fl

wt/fl

;
,

n=13) and and wild type controls (n=23) were compared. * p<0.05 ** p<0.01, 2way repeated measures ANOVA. Right: Total horizontal distance travelled in an
open-field chamber over 60 minutes. * p<0.05 ** p<0.01, one-way ANOVA
followed by Tukey’s post test.
All error bars indicate S.E.M.

91

Figure 23. miR-128 modulates motor activity via ERK activation in D1-MSNs.

92

5.4 miR-128 suppresses supersensitive dopamine response
Firing of D1 MSNs induced either by pharmacological activation of D1
receptors or by direct optogenetic stimulation induces locomotor activity (134). It
is therefore likely that the hyperlocomotion observed in Drd1a-cre; miR-128-2fl/fl
mutants reflects a higher population firing rate of D1-MSNs. To test if this
baseline difference was accentuated, preserved or occluded in the presence of
further stimulation, we tested the locomotor activity of Drd1a-cre; miR-128-2fl/fl
mutants in the presence of a D1 receptor specific agonist. Low dose of agonist
induced locomotor activity in wild type mice, with the peak occurring about 30
minutes post injection. Interestingly, Drd1a-cre; miR-128-2fl/fl mutants showed an
even greater locomotor response with a similar duration to peak activity and
slower return to baseline (Figure 24a).
The pharmacological activation of D1-MSNs by cocaine leads to ERK
signaling activation, phosphorylation of Histone H3 at Serine S10 (H3S10) and
upregulation of immediate early genes (IEGs) (146, 153). Similarly, D1-MSNs of
the dopamine-depleted striatum are characterized by a supersensitive ERK
response, H3S10 phosphorylation, and transcriptional activation in response to
L-DOPA.
Besides basal ERK2 elevation, D1 agonist stimulation induced further
increases in ERK2 phosphorylation in Drd1a-cre; miR-128-2fl/fl mutants at a dose
that induced almost no increase in ERK2 phosphorylation in control mice (Figure
24b). This result suggests that mutant D1-MSNs are supersensitive in a manner
reminiscent of those in dopamine-depleted striata.
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Figure 24. miR-128 suppresses supersensitive dopamine response.
a, Locomotor response to dopamine agonist is heightened by the loss of miR-128.
Horizontal distance travelled in an open-field chamber shown 5 minute intervals.
Saline and D1-agonist SKF81297 were injected intraperitoneally 10 and 20 minute
after introduction to the chamber. Drd1a-cre; miR128-2fl/fl (n=25) and controls
(n=30). * p<0.05; ** p<0.01; *** p<0.001, Welch's t-test.
b, Drd1a-cre; miR-128-2fl/fl mutants show supersensitivity of Erk2 phosphorylation
in response to dopamine agonist. Mutants and controls were injected with either
saline or D1-agonist SKF81297 (n=5 each) and phosphorylation levels of P42
were quantified by western blot, normalized to total P42 levels and expressed
relative to mean control levels. Representative blot is shown. * p<0.05, two-way
ANOVA Tukey's post test.
c-d, Neuronal activation by dopamine agonist is increased by loss of miR128.
Mutant (Drd1a-cre; miR128-2fl/fl; Drd1a-eGFP-L10a) and control mice (miR128-2fl/fl;
Drd1a-eGFP-L10a) are injected with either saline or agonist and sacrificed 30
minutes later and total striatum is dissected for flow cytometry. c, Representative
nuclei counts showing eGFP-positive D1-MSN nuclei and activation as assayed
by phosphorylated Histone H3S10. d, Number of activated D1 MSN nuclei was
counted and expressed as percentage of total D1 MSN nuclei. Each symbol
represents sample for one mouse. * p<0.05, 2-way Anova followed by Tukey’s
post-test.
e-f, Transcriptional activation by dopamine agonist is increased. Mutant (Drd1acre; miR128-2fl/fl; Drd1a-eGFP-L10a) and control mice (miR128-2fl/fl; Drd1a-eGFPL10a) were injected with either saline or agonist and sacrificed 30 minutes later
and polysome-associated transcripts were quantified by either microarray or
qRT-PCR. e, Hierarchical clustering was performed on probes corresponding to
immediate-early genes (IEG). Only agonist-injected samples cluster according to
genotype. f, Selected immediate early genes and Darpp32 were quantified by
qRT-PCR from polysome associated transcripts and expressed relative to control
saline samples. ** p<0.01, *** p<0.001, 2-way ANOVA followed by Tukey’s posttest. All error bars indicate S.E.M.
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Figure 24. miR-128 suppresses supersensitive dopamine response.
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To extend this observation, we tested if locomotor and ERK
supersensitivity is accompanied by potentiated histone phosphorylation and
transcriptional response. Using Drd1a-cre; miR-128-2fl/fl mutants and control mice
expressing tagged ribosomes in D1-MSNs - Drd1a-cre; miR128-2fl/fl; Drd1a-eGFPL10a, we were able to assay the extent of these responses in a cell-specific
manner.
To quantify H3S10 phosphorylation, we enlisted the help of Dr. Melanie
von Schimmelmann. EGFP-positive nucleoli in the nuclei of D1-MSNs allow
quantification of histone activation in the D1-MSN population. Drd1a-cre;
miR128-2fl/fl; Drd1a-eGFP-L10a mutants and controls were injected with either
saline vehicle or D1 agonist SKF81297. Animals were sacrificed 30 minutes later
and striata dissected and nuclei were isolated. Nuclei were then incubated with
antibodies against phosphorylated H3S10 and processed for flow cytometry.
Agonist induction resulted in a higher percentage of phospho-H3S10 positive
D1-MSNs (Figure 24c,d).
To quantify transcriptional activation, Drd1a-cre; miR128-2fl/fl; Drd1a-eGFPL10a mutants and littermate controls were injected with either saline vehicle or
D1 agonist SKF81297. Animals were sacrificed 30 minutes later and striata
rapidly dissected and processed for polysome immunoprecipitation and RNA
isolation followed by microarray analysis. IEGs were defined as genes
upregulated in control mice by at least 5 fold in response to agonist (19 unique
genes). Cluster analysis of IEG expression levels show that mutant samples
segregated from control samples upon agonist injection (Figure 24e). Based on
two-way ANOVA analysis, aggregate IEG expression levels were higher in
mutants than controls upon induction, confirming greater transcriptional
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activation. Selected IEGs were quantified further by qRT-PCR and these showed
significantly higher agonist-induction in mutants (Figure 24f).
We have shown earlier that miR-128 overexpression suppresses
endogenous ERK activation. We therefore tested if excess miR-128 suppresses the
development

of

behavioral

supersensitivity.

Firstly,

transgenic

mice

overexpressing miR-128 showed a reduced locomotor response to acute D1agonist administration, with similar induction kinetics (Figure 25a).
We further tested if miR-128 could suppress supersensitive responses in
the hemiparkinsonian mice model. To do this, we made use of an assay of
rotational behavior in unilateral 6-OHDA lesioned mice. In this model, both the
extent of denervation and D1-MSN supersensitivity can be assayed by
quantifying rotational behavior. Systemic administration of cocaine results in
ipsilateral rotations toward the side of the lesion due to the imbalance of
dopamine releasing terminals, while systemic administration of either L-dopa or
D1 receptor agonist, result in contralateral rotations due to supersensitive
responses in the lesioned striatum (156) (Figure 25b).
We performed unilateral lesions of transgenic mice in which 6-OHDA was
stereotactically injected into the left striatum and vehicle was injected into the
right striatum. After a 3-week recovery period, rotational responses were
quantified. Mice did not result in net rotations in either direction at baseline.
Cocaine injection led to similar net ipsilateral rotations in control and transgenic
mice. In contrast, upon D1 agonist injection, transgenic mice showed lower net
contralateral rotation compared to controls indicating reduced D1-MSN
supersensitivity (Figure 25c).
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Figure 25. Transgenic miR-128 expression suppresses excitability.

Figure 25. Transgenic miR-128 expression suppresses excitability.
a, Locomotor response to dopamine agonist is dampened by increased miR-128.
Horizontal distance travelled in an open-field chamber shown 5 minute intervals.
Saline and D1-agonist SKF81297 were injected intraperitoneally 20 and 40 minute
after introduction to the chamber. Camk2a-cre; ROSAmiR-128/miR-128 and controls
(n=11 each). * p<0.05, ** p<0.01, Welch's t-test.
b-c, Unilateral 6-OHDA lesions were performed on Camk2a-cre; ROSAmiR-128/miR-128
and control mice, by stereotactic injection into the left striatum. Vehicle injections
were performed on the right striatum. Rotational responses to cocaine and D1
agonist SKF81297 were measured after a 3 week recovery period.
b, Cocaine injection induces ipsilateral rotations due to presence of functional
dopamine terminals in the unlesioned striatum. SKF81297 induces contralateral
lesions due to increased dopamine response of D1-MSNs in the lesioned
striatum. c, Overexpression of miR-128 suppresses contralateral rotation in
response to D1 agonist. (n=10 per genotype) ** p<0.01 Welch’s t-test. All error
bars indicate S.E.M.
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5.5 miR-128 depletion impairs learning and memory
ERK-dependent changes are crucial to synaptic and transcriptional
mechanisms of plasticity and the loss of ERK signaling impairs animal
performance in memory tasks and the ability to acquire new associations.
In cocaine-conditioned place preference (CPP), cocaine administration is
paired with a specific context during training phase. At the test phase, test
subjects are allowed to roam freely between cocaine and saline-paired chambers.
Successful conditioning results in substantially more time spent in the cocainepaired chamber due to the rewarding effects of cocaine (Figure 26a). Inhibition of
ERK activation during conditioning abolished place preference (146), while in
models with enhanced ERK2 signaling, mice showed increased cocaine
sensitization and increased CPP responses (161). Therefore, we tested if Drd1acre; miR128-2fl/fl mutants have higher CPP responses too. We found that these
mutants show a significantly reduced CPP response compared to controls, as
shown by the lower duration spent in exploration of the cocaine-paired chamber
(Figure 26b).
To examine this effect further, we examined the performance of miR-128
depleted mutant mice in a separate behavioral task. In the novel object
recognition task, experimenters make use of the robust, innate rewarding effects
of novelty to produce a heightened exploratory response. This behavior is
analogous to the novelty-induced hyperactivity upon inital exposure to the openfield chamber. In this paradigm, mice are trained by exposure to two identical
objects in a chamber to which the mice have been previously acclimated. At 1
hour and 24 hours after training, test phases are conducted in which one of the
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objects is replaced by a novel object prior to the introduction of the test subject
into the chamber. Mice spend more time in exploration directed toward the novel
object compared to the training object, indicating retention of memory of the
trained object (Figure 26c). ERK suppression by hippocampal injection of MEK1
inhibitor during the training phase spares short-term memory (10min posttraining) performance but severely impairs long-term memory (24 hours posttraining) (162).
As the majority of homozygous Camk2a-cre; miR-128-2fl/fl mutants suffer
from frequent seizures and die before 2 months of age, we performed this test on
heterozygous Camk2a-cre; miR-128-2wt/fl mutants. Both mutant and control mice
spent equal time exploring both objects during the training phase and
significantly increased novel-object exploration during the 1 hour test phase.
Interestingly, mutant mice showed severe impairments during the 24 hour test
phase (Figure 26d).
Since ERK inhibition impairs acquisition and retention of learned
associations, we expected that increased ERK sensitivity of miR-128 mutants
would exhibit improved performance in learning and memory tasks. The reasons
for this discrepancy will be discussed in the final chapter.
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Figure 26. miR-128 depletion results in learning and memory deficits.
a, Schematic shows cocaine place preference in a 3-chamber test set-up. During
test phases, mice are placed in center chamber and allowed to freely explore all 3
chambers for 5 minutes. During conditioning, mice are injected with either saline
or cocaine (15 mg/kg) and placed in the correspondingly paired chamber for 15
minutes. The other pairing is performed 4 hours later. This conditioning protocol
is repeated daily for 3 days. Free exploration test is performed on the 4th day.
b, Drd1a-cre; miR128-2fl/fl mutants are less efficiently conditioned by cocaine. Ratio
of duration spent in cocaine-paired chamber to duration spent in saline-paired
chamber is shown.
(n=12 per group). ** p<0.01, 2-way ANOVA followed by Bonferroni post test.
c, Novel object recognition task. During training phase, mice are allowed to
freely explore a chamber with 2 identical objects. Mice are tested for recognition
memory at 1 hour and 24 hours after training phase, with replacement of one of
the training objects in each case.
d, Camk2a-cre; miR-128-2wt/fl heterozygous mutants are impaired for long-term
memory object recognition memory. Line graphs show time spent exploring the
novel object as proportion of total time spent exploring both objects. (n=15 per
group) ** p<0.01, 2-way ANOVA followed by Bonferroni post test.
All error bars indicate S.E.M.
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Figure 26. miR-128 depletion results in learning and memory deficits.
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5.6 Summary
In summary, miR-128 loss induces basally elevated ERK2 signaling in D1MSNs and the inhibition of ERK2 was sufficient to rescue basal hyperactivity,
probably via ERK-dependent increases in neuronal excitability. In the absence of
miR-128, D1-MSNs exhibit behavioral and ERK signaling supersensitivity similar
to that which develops after dopamine depletion. This is also accompanied by a
similar

supersensitive

transcriptional

response.

Furthermore,

miR-128

overexpression was able to suppress behavioral supersensitivity. Lastly, we
examined the performance of miR-128 mutants in learning and memory tasks
and showed that their performances were strongly impaired, suggesting that
ERK signaling hyperactivation does not necessarily enhance learning and
memory.
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Chapter 6 Discussion
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6.1 Summary of findings
In this section, I will first summarize the key findings of the work
presented here and subsequently expand on a few specific topics in separate
sections.
We have demonstrated that segregated miRNA expression across
neuronal types in the adult brain has enormous functional consequence. Prior
studies found strong enrichment of miR-128 in projection neurons relative to
interneurons of the forebrain. We demonstrated that the deletion of miR-128 in
the former alone was sufficient to recapitulate fully the fatal epilepsy and severe
hyperactivity observed upon ubiquitous deletion. We further extended this
finding by showing that miR-128 is enriched in D1-MSNs over D2-MSNs of the
striatum and that deletion of miR-128 in the former but not the latter was
sufficient to recapitulate fully the hyperactivity induced by striatal deletion of
miR-128.
By employing a combination of tools to identify RISC-associated
transcripts and translationally repressed transcripts, we were able to isolate
primary targets of miR-128 repression in an unbiased manner. This strategy
allowed us to identify a relevant pathway (ERK signaling), the specific
dysregulation of which accounts for some aspects of the behavioral changes. Our
results strongly suggest that such a strategy would be very useful in other
studies of miRNA function.
Finally, we showed that endogenous miR-128 expression suppresses ERK
pathway activity and limits the excitability of neurons. This in turn could explain
the development of spontaneous, fatal seizures and severe hyperactivity upon
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miR-128 deletion. miR-128 suppresses a ERK hypersensitive response to
dopamine and represses the supersensitivity of D1-MSNs in the dopaminedepleted striatum. This effect suggests clinical use to miR-128 in the treatment of
neurological disorders in which hyperexcitability plays a major role, for example
epilepsy and L-dopa induced dyskinesia.
In the following sections, I will discuss our miRNA target search strategy
and other methods that might offer an improvement over the one we have
employed. I will discuss the implication of ERK regulation by miR-128 for
plasticity and learning, as well as possible roles of this regulation in other cell
types. Finally, I will suggest further studies that might clarify the role of miR-128
in human dyskinesias and epilepsy.
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6.2 In-vivo tools for primary target identification
In our search of physiologically relevant targets of miR-128, we have
made use of two complementary tools: Ago2 CLIP-seq to profile RISC-associated
mRNAs and TRAP-ribosomal profiling to profile transcript derepression in the
absence of miR-128. This approach is a considerable improvement over
methodologies used in previous studies undertaken to identify miRNA targets,
mostly involving mRNA quantification.
MiRNA-dependent repression of target expression involves translational
inhibition (reduced ribosomal association) and mRNA degradation (reduced
mRNA quantity). These two processes are largely correlated but not necessarily
linked, as such, quantification of ribosomal association is less restrictive and
would include translationally-repressed transcripts for which no reduction in
mRNA levels occur.
Ribosomal profiling experiments have previously been used in the study
of miR-223-mediated repression in culture-differentiated neutrophils (79). The
use of tagged ribosomes in TRAP technique allows cell-type specific expression
profiling on rapidly dissected brain tissue and improves experimental resolution
by excluding non-cell autonomous expression changes.
Other alternatives to ribosomal profiling include protein quantification
using metabolic labeling experiments (163). However, such experiments are as
yet difficult to implement in living animals (164), are also just beginning to be
implemented in a cell-type specific manner (165) and is likely to offer only
marginal improvements over ribosomal profiling.
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Expression changes upon miRNA loss reflect not just the primary
derepression of primary targets, but also the extensive secondary changes that
invariably accompany chronic miRNA loss. To sieve out primary targets from
secondary changes, in-silico predicted targets are often used. This approach
depends greatly on the presence or absence of conserved complementary seed
sequences in the altered transcripts, without evidence for whether such sites do
indeed confer RISC association. Our method uses physiological RISC binding to
identify primary targets.
All binary classification methodologies necessarily involve a trade-off
between false positive rate and false negative rate. Because most if not all targets
are repressed by miRNAs, and derepression of single targets are highly similar,
changes in mean derepression can be used as a proxy of false positive rate. High
mean derepression of a candidate target upon miRNA loss correlates with low
false positive rate. By this measure, the use of CLIP-seq positive 6mer-containing
targets as we have done produces a lower false positive rate than the use of all
6mer-containing targets in the genome. The use of conserved Targetscan
predictions appears to produce an even lower false positive rate. However,
previous studies have shown that non-conserved sites are also highly responsive
to miRNAs, suggesting that limiting by conservation scores is too restrictive.
False negatives are more difficult to estimate from our data, but could
arise in a number of situations. In some cases, full seed complementarity is not
an absolute requirement for miRNA binding if non-canonical interactions exist
along the rest of the miRNA. Future iterations of CLIP-seq might include such
possibilities. However, the sequence determinants of such of "extra-seed"
interactions are less well-defined and previous estimates suggest such pairings
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are relatively rare. A more important source of false negatives is the detection
limit imposed by RNA-sequencing. This group of false negatives would include
target transcripts that are expressed at very low quantities, and transcripts of
which only a small proportion are bound to the RISC-complex. Repeating the
protocol using higher sequencing depth would address this issue to some extent.
In summary, we have used more physiological measures of derepression
and RISC association, which allows us to reduce false positives without arbitrary
sacrifices in sensitivity. New techniques in protein level quantification and the
incorporation of known cis-determinants of targeting are likely to improve this
process. New insights about miRNA-RISC biology might be gleaned from a
quantitative and global view of miRNA targeting and repression.
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6.3 Tuning and buffering of targets and ERK signaling
We have shown that primary target genes, in aggregate, respond in a
bidirectional fashion to depleted and excess miR-128 levels. Most of these genes
show a very mild repression by miR-128 in line with the fold changes observed
by other groups. As transcription is an inherently noisy process, it is difficult to
see how such mild changes could persist in single cells in the presence of
stochastic fluctuations. In this and previous studies, the measured repression is a
population mean of large cell populations, what remains unclear is if miR-128
repression has an effect on population variance. This could be determined by
quantifying mRNA levels in single neurons or estimated using bins of small
fixed numbers of neurons. If the mild repression level is a result of miR-128
buffering of stochastic transcriptional noise, one would expect the population
variance of target expression to be increased substantially in the absence of miR128. Conversely a strict tuning effect would preserve temporal variability in each
neuron and preserve variability across the population of neurons.
We have also shown that miR-128 levels exert a specific and bidirectional
regulation of ERK2 phosphorylation, although it is similarly unclear how the
profile of the response is altered.
ERK signaling response is highly cooperative in Xenopus oocytes and in
in-vitro systems (166, 167), converting graded signals into an all-or-none
response. In mammalian cells, a switch-like response is found in thymic selection
and neuronal differentiation (168, 169), while a more graded response is
observed in other conditions (170). Increased steady-state phosphorylation levels
in D1-MSNs might occur through a number of ways: decreased cooperativity,
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reduced threshold for activation, or increased background by independent
processes, or a mixture of the above.
Additional experiments to address this question could be performed in
striatal slice cultures. Steady state phospho-ERK levels in striatal slices exposed
to different levels of glutamate or KCl can be quantified for control and D1mutant slices. These experiments could clarify which subsets of primary targets
exert the greatest contribution to elevated steady state ERK signaling.
In conclusion, examination of population variance of miR-128 targets and
examination of the population variance and input-dependence profile of ERK
signaling are both interesting avenues to examine in detail the key primary
effects of miR-128 regulation.
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6.4 ERK signaling in neurons and the regulation of excitability
Among the electrophysiological consequences of miR-128 loss in D1MSNs, we found a substantial increase in dendritic membrane excitability.
Intrinsic dendritic or neuronal excitability is increasingly thought to be a vital
mechanism of metaplasticity - processes which alter the ability to generate
synapse-specific plasticity (LTP or LTD) (171, 172). Kv4.2 regulation of dendritic
branch excitability itself could be a form of persistent information-encoding
change that allows specific input-patterns to promote persistence of LTP at
synapses on the branch (173, 174). A similar process appears to occur in D1MSNs. Coordinate excitatory inputs induce an "up-state" characterized by
depolarized distal dendritic potential, during which LTP induction is enhanced.
D1 receptor activation enhances distal excitability and increases the duration of
these "up-states".
A change in excitability is sufficient to account for the altered behaviors
observed in Drd1a-cre; miR128-2fl/fl mutants. 1. Endogenous inputs would
produce a higher firing probability that is sufficient to trigger locomotor activity,
thus accounting for basal hyperlocomotion. 2. Longer "up-state" durations could
enhance NMDA receptor activation that is required of ERK activation. This could
account for the apparent ERK hypersensitivity upon D1 agonist stimulus.
Our results studying the effects of miR-128 on learning and memory
provide important clues as to the role of miR-128 in ERK regulation. While the
general dis-inhibition of ERK signaling potentiates intrinsic excitability and
transcriptional responses, pairing of cocaine-induced dopamine signaling with
contextual information is impaired. In light of the role of ERK in coincident input
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detection I would venture to speculate that miR-128 loss produces a fundamental
dysfunction of ERK signaling such that these signals no longer adequately
represent and transduce external information. For example, "up-states" in D1MSNs might be dissociated from cortical inputs that carry information about the
context. In this model, ERK supersensitivity and enhanced transcriptional
response enhances the induction of plasticity mechanisms. However, ERK
activation could be "noisy" and become engaged even in the absence of
physiological inputs, resulting in the strengthening of "inappropriate" synaptic
associations.
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6.5 miR-128 in other contexts
Given that miRNA targets are highly dependent on cellular context, it is
unclear if miR-128 has a similar role in regulating ERK in other cell and tissue
types. That being said, the known miR-128 expression in some specific cell types
suggests that ERK regulation might be a significant component of miR-128
function in these specific contexts as well. I will highlight some of these examples
below and speculate on the possible roles play by miR-128.
Thymocyte development is the process of producing of mature T
lymphocytes that are able to respond to foreign antigens and are tolerant of self
antigens. Within the thymus, immature thymocytes pass through a number of
specific stages identifiable by surface markers, which correlate with a number of
important processes such as gene rearrangement and positive and negative
selection.
Both miR-128 and its host gene TARPP are strongly upregulated
beginning at the DN3 stage, reaching a maximum during the DN4 stage (175,
176).

At

the

DN3

stage

(CD4-CD8-CD44-CD25+),

thymocytes

initiate

rearrangement of the TCR" loci. Productive rearrangement leads to its
expression in a complex with the alpha-T cell receptor (pre-TCR). This
developmental

stage

coincides

with

beta-selection

and

#"/$%

lineage

divergence, both of which depends on pre-TCR signals which are transduced
primarily by ERK signaling. It has been shown that the strength of ERK signaling
downstream of pre-TCR provides an instructive signal for the commitment to the
#" or $% lineage (177, 178). A strong ERK signal favors $% lineage differentiation
while the opposite favors #" lineage commitment.
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In light of this model, the expression of miR-128 suppresses the signaling
response to favor #" lineage commitment. In agreement with this, our
preliminary data suggests that constitutive deletion of miR-128 results in a small
increase in the population of $% positive T cells in the thymus.
Conversely, miR-128 expression begins to decrease in the DP stage
(CD4+CD8+). Among the vital thymic selection processes that occur in this stage
is positive selection, in which functional #" TCR-MHC (major histocompatability
complex) interaction results in an instructive signal that permits further
maturation. Intracellular signaling during positive selection is transduced by the
ERK pathway. Transition of DP thymocytes into a ERK hypersensitive condition
is required for the amplification of weak TCR-MHC signals and for positive
selection (179). Indeed, loss of the transcriptional program required to induce
this ERK hypersensitivity results in failure of positive selection. In this model,
miR-128 reduction might coincide with and contribute to the induction of ERK
hypersensitivity.
Leukemia is a form of cancer characterized by uncontrolled increase in
circulating white blood cells. Among acute forms of leukemia, acute
lymphoblastic leukemia (ALL) is derived from lymphocytic precursors, which
also give rise to thymocytes, while acute myeloid leukemia (AML) is derived
from precursors of red blood cells and platelets.
miRNA profiling of ALL and AML samples and cell lines show that miR128 is among the most differentially expressed among the 2 groups (180). High
miR-128 DN4 stage is also highly proliferative, so at minimum miR-128 might
not be tumor suppressing in the lymphoblast lineage, as is the case in other
cancers. It might be interesting to speculate that commitment to the
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lymphoblastic lineage confers changes that permit oncogenic property of miR128 in ALL or reduce the tumor suppressing effects in ALL.
The tumor suppression properties of miR-128 is better characterized in
other cancers, and has been studied as a potential therapeutic tool. For example,
low miR-128 levels correlate with aggressive gliomas. miR-128 is shown to
suppress stem-cell renewal factor Bmi-1 and reduce glioma proliferation (181). In
another study, miR-128 suppresses oncogenic receptor tyrosine kinases to
suppress proliferation and enhance differentiation (182). As ERK and MAP
kinase signaling are key transduction events downstream of receptor tyrosine
kinases, it might be possible that a broader examination of miR-128 targets in
gliomas might identify further nodes of regulation.
In summary, our finding that miR-128 exerts a sensitive control of ERK
signaling might be informative about the role of miR-128 in other contexts in
which ERK signaling is an important transducer of external signals.

116

6.6 miR-128 in Parkinson's disease and human epilepsy
We have shown that substantial similarities exist between the D1-MSN
hyperexcitability in miR-128 mutants and that induced upon dopamine
depletion. D1-MSN hyperexcitability develops soon after dopamine depletion
and persists even after dopamine replacement for example upon chronic LDOPA treatment. However, the primary cause of this phenomenon is not well
understood. Further experiments could address if miR-128 depletion occurs
upon dopamine depletion and if this might be a primary cause of ERK
hypersensitivity in this pathological condition. As post-depletion D1-MSN
hyperexcitability is thought to share mechanisms that lead to the development of
L-DOPA induced dyskinesias, this has clear clinical implications for the
treatment of Parkinson's disease.
The fact that reduced miR-128 can lead to pronounced epilepsy in mice
suggests that miR-128 and its target genes might contribute to genetic
predisposition in human epilepsies. Human idiopathic epilepsies have a
substantial genetic component, with an estimated heritability of over 80% from
twin studies (183). While rare cases of genetic epilepsy have monogenic
determinants (184), mostly involving mutations in voltage- or ligand-gated ion
channels, the vast majority of idiopathic epilepsies are presumed to have
complex polygenic causes and significant genetic-environmental interactions.
A common method for the identification of major susceptibility genes is
the use of linkage mapping and positional candidate gene analysis but most
studies have focused on protein coding genes included within the linkage region.
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To see if miR-128 could be a susceptibility gene, I looked for studies that
found linkage regions overlapping with one or both of the human miR-128 loci.
In one analysis of childhood absence epilepsy involving over 300 individuals
from 63 families, the authors found a large linkage region spanning 3p23-3p14,
which overlaps with human miR-128-2 (185). In a separate study, the authors
analyzed members of a multi-generation family presenting with autosomal
dominant generalized epilepsy. This study found significant linkage in a much
narrower region that also overlaps with human miR-128-2 (186). Interestingly,
the epileptic condition in this family is accompanied by mental retardation, in
agreement with the learning and memory deficits we observed in our miR-128
mutants. These studies suggest that genetic mutations resulting in aberrant miR128 sequence or miR-128 expression might be a primary determinant in these
cases.
Follow-up studies might be complicated by the small size of miRNAs, and
by the fact that mutations in the hairpin are likely to be strongly deleterious.
Instead, mutations are much more likely to cause expression changes. Besides
mutations in the host gene promoter, mutations that alter the tertiary and
secondary structure of the hairpin region and mutations that affect Drosha
processing could also result in reductions in mature miR-128 levels. This makes
the demonstration of a causative allele involving miR-128 particularly
challenging, especially in the absence of a strong candidate allele.
Whether miR-128 is a naturally occurring epilepsy determinant or a cause
of D1-MSN hyperexcitability, our data suggests that miR-128 expression might
have therapeutic value. Such a treatment might require a mechanism to increase
specificity to projection neurons to avoid potentially deleterious overexpression
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in interneuron populations. Further experiments overexpressing miR-128 in local
interneuron populations would help to identify these adverse effects if they do
exist.
In conclusion, our findings presented here could have substantial
implications for future clinical and therapeutic research.
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Material and Methods
Mice
All procedures involving animals were performed in accordance with the
National Institutes of Health Guide for the Care and Use of Laboratory Animals
and were approved by the Rockefeller University Institutional Animal Care and
Use Committee. All mice were generated and maintained in C57BL6/J
background.

Generation of mice with neuron-specific tagged-Ago2 expression.
Transgenic mice expressing a Cre-inducible FLAG-HA2-tagged Ago2 under the
control of the Rosa26 promoter were generated as previously described (Schaefer
et al., 2010; Sasaki et al., 2006; the STOP-eGFP-ROSA26TV vector was a gift from
K. Rajewsky, Harvard Medical School, Boston, MA). Rosa-Stop fl/fl-Flag-Ago2
mice were bred to Camk2a-Cre (provided by G. Schuetz, German Cancer
Research Center, Heidelberg, Germany;) (126) , Drd1-Cre (EY262) and A2a-Cre
(KG139) transgenic mice obtained from Gensat (187) to generate Camk2a-Cre;
Rosa26-Ago2-Flag , Drd1-Cre; Rosa26-Ago2-Flag, and Drd2-Cre; Rosa26-Ago2Flag mice.
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Generation of mice with a conditional deletion of miR128-1 and miR128-2.
Subcloning of targeting vectors
A region of the miR-128-1 or miR-128-2 genomic locus containing the arms of
homology was recombinogenically subcloned from a BAC clone (miR-128-1:
RP24-574G14, miR-128-2: RP24-242F13, C57Bl/6J, CHORI, Oakland CA, USA)
into pBlueScriptIIKS+ as described (188), using amplicons that insert an AscI site
and a XhoI site to flank the subcloned region.
PCR primers used for subcloning:
mir-128-1
5' ccttcatgttatgccctcatccctttatcacacaaatctgtgtagttttcggcgcgccattcgccctatagtgagtcg
5' aatcttctaaatttccatttgagcacctagttcatatgtaatttagattcctcgaggcttggcgtaatcatggtc
mir-128-2
5' cgaaaaatattttcatttattcttcgaaactttcatacattcatacaatgtggcgcgccattcgccctatagtgagtcg
5' tcaggcctgccagccttctgtctactgtttaatgactgacagccagtgaactcgaggcttggcgtaatcatggtc

Modification of targeting vector for miR128-1
pZeroloxP-FRT-neoR-FRT(-) plasmid was modified to replaced unique EcoRI site
with unique SmaI site. Modified plasmid was digested with NsiI and fragment
containing single loxP site and FRT-flanked neo gene was inserted into unique
NsiI site in targeting vector and screened to proper orientation. For insertion of
second loxP site, oligonucleotide fragments containing loxP sequences were
annealed and inserted into the unique SpeI site:
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Modification of targeting vector for miR128-2
pZeroloxP-FRT-neoR-FRT(-) plasmid was modified to introduce SmaI sites by
insertion of oligonucleotide fragments at the SacI/ApaI site and at the Acc65I
site. Modified plasmid was digested with SmaI and fragment containing single
loxP site and FRT-flanked neo gene was inserted into unique SmaI site in
targeting vector and screened to proper orientation. For insertion of second loxP
site, oligonucleotides containing loxP sequences were annealed and inserted into
a unique HindIII site.

Homologous recombination
For both targeting vectors, modified regions of homology were excised from
pBluescript with XhoI and AscI digests and inserted into similarly digested
pDTA-TK to produce final targeting constructs. Targeting constructs were
linearized with NotI and E14 CY2.4 embryonic stem cells (homozygous
C57Black/6JTyr-C-2J background with natural mutation in tyrosinase gene) were
transfected and screened for successful recombination using southern probe.
Positive clones were confirmed using an alternative Southern probe and by PCR
sequencing of modified region. Positive clones were used to produce chimeric
mice as described. Chimeras were crossed to C57BL6/J mice and germline
transmission was assessed by coat color, PCR and southern blot analysis.
Germline deletion of the FRT-flanked neo gene was accomplished by crossing
mice carrying the targeted alleles with FLPe- transgenic mice (3). Germline
deletion of miR-128-1 and miR-128-2 was achieved by crossing mice carrying
floxed alleles to transgenic mice that express Cre-recombinase under the
ubiquitously expressed CMV promoter (CMV-Cre mice, Jackson Laboratory).
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Postnatal, neuron-specific deletion in the mouse forebrain was achieved by
breeding mice carrying floxed alleles to Camk2a- Cre mice (126). Drd1-Cre (EY262)
and A2a-Cre (KG139) transgenic mice were obtained from Gensat (187) and Drd1Cre; miR128-2fl/fl mice and A2a-Cre; miR128-2 mice were generated by breeding
to miR128-2fl/fl mice.

PCR Genotyping
Routine genotyping of miR-128-1 mice was performed using following primers:
5' tctggaccaaatgaaccaaag
5' ccgcaatgctgcctatattc
5' gcctgaagaacgagatcagc
5' gcagtcatgcaagcagctat
Wild type allele: 194bp
Null allele: 282bp
Floxed allele: 336bp
Routine genotyping of miR128-2 mice was performed using following primers:
5' cgccttttagtttcccacag
5' gaccacacagcaagcaggta
5' aaagacgggaccattcacat
5' tctctcgtgggatcattgttt
Wild-type allele: 185bp
Null allele: 531bp
Floxed allele: 306bp
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Generation of mice with a neuron-specific overexpression of miR-128
Targeting vector for homologous recombination at the ROSA26 locus was
generously provided by K. Rajewsky. A 1kb region including miR128-2 hairpin
was amplified from genomic DNA with the following primers and cloned into
unique xhoI site in the targeting vector:
5’ aaaggcgcgccacgtgactaaaaggcgcgaggagat
5’ aaaggcgcgcctacgcattcctgtacggttg
Modified targeting vector was linearized by NotI and used to generate chimeras
as above. Successful germ line transmission was assessed by coat color and
confirmed by PCR and southern analysis. Postnatal, neuron-specific miR-128-2
overexpression in the mouse forebrain was achieved by breeding mice to
Camk2a- Cre mice (126).

CLIP-seq analysis
In vivo Cross-Linking and ImmunoPrecipitation (CLIP) procedure.
Mice were sacrificed at 8 to 14 weeks; forebrains were excised and triturated to
disrupt tissue. Immunoprecipitation on the UV-crosslinked triturated tissues was
performed as described (61) with the following modifications to the protocol:
After UV cross-linking the frozen lysates are sonicated to improve tissue
homogenization. RNase digestion with RNase A is done twice during out
protocol once before IP (using one fourth the concentration of RNAse A used by
Chi et al) and once after IP (using one twentieth the concentration of RNAse A
used by Chi et al). 30µl magnetic beads pre-coupled to the M2 FLAG antibody
(M8823, Sigma) have been used for each IP on half a forebrain in 1.2 ml after pre-
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blocking the beads with 2% BSA, 1% t-RNAs and 1% salmon sperm for 1.5 hrs at
4o C. Unlike Chi et al. we did not transfer RNA-protein conjugates to a membrane
during RNA purification and we did not use hot labeled adapters in the
preparation, instead RNA was directly decrosslinked from protein after
extensive washing.

Illumina Sample Preparation and Sequencing.
The small RNA sample preparation kit, version 1.5 (Illumina) was used for
library preparation with subtle modifications. Since low concentrations of RNA
was purified from the CLIP procedure, as measured by Quant-iT RiboGreen
RNA Assay (Invitrogen), the following modifications were made to the small
RNA sample preparation kit (Illumina) to allow for extremely low RNA input:
Both the v1.5 sRNA 3’ Adapter and the SRA 5’ Adapter were diluted 10 times in
nuclease-free water compared to standard protocol before adapter ligation. The
RT reaction was doubled (resulting in a final RT volume of 20 µl instead of the
standard 10 µl), all of which was used for the downstream PCR reaction. To
allow for the larger volume of RT product 10 µl less water was used in the PCR
step, resulting in a final PCR volume of 50 µl. Instead of the 12 cycles of PCR
directed in the standard protocol 15 cycles were performed to increase output.
Preparation of RNA for sequencing was performed in two sets: First, four Ago2Flag and two control CLIP samples were prepared using RNA from one CLIP
procedure each; from half a mouse forebrain each. At the end of the Illumina
small RNA protocol a size range of 90 bp to 150 bp of final PCR product was
purified; this size range contains both Ago2 associated miRNA and mRNA target
sites. The second set of samples consisted of four Ago2-Flag and two control
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samples, which each was prepared from a pool of RNA from four CLIP
procedures; amounting to CLIP RNA from two mouse forebrains per sample. At
the end of the Illumina small RNA protocol for this set of samples the products
were purified in a band from 110 to 150 bp containing Ago2 associated mRNA
target sites. All mRNA target site containing samples were Solexa sequenced
Prepared samples were amplified onto flowcells using the Illumina cluster
station per manufacturer protocol and sequenced on the Illumina GAIIx platform
76 cycles. Raw sequencing data was processed using the onboard SCS/RTA
software yielding 76 bp reads.

Data pre-processing and miRNA detection
Sequence reads were filtered to remove low quality reads, using a minimum
average cutoff quality score of 25 over 75% of the read. Sequence reads were
trimmed of any identifiable adapter sequence using several variations on the
adapter sequence supplied by Illumina. Reads not containing adapters were
aligned to the mm9 genome build using bowtie, allowing for 3 mismatches for 76
bp reads. The last 8 bases were not used during the alignment to allow for
incomplete adapter trimming. For those reads that did not align initially were 3’
trimmed and re-aligned at 36 bp allowing 2 mismatches to account for lower
quality sequence at the 3’ end of the read. Adapter-trimmed reads from long
libraries were aligned allowing for 2 mismatches.
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Detection of mRNA target sites clusters:
For the downstream analysis of mRNA targets, clusters of Ago2-Flag reads were
detected using a filtering approach described here. To reduce contributions of
nonspecifically binding RNA species from cluster detection any Ago2-Flag read
within 30 bp of overlapping reads from the grouped control samples were
discarded. Then only reads occurring in at least two filtered Ago2-Flag samples
were kept and 30 nucleotides of genomic sequence was added to each end of the
filtered reads. These reads were filtered to only retain clusters composed of
minimum of 10 overlapping reads. Genomic distribution of clusters was
examined by use of Cis-regulatory Element Annotation System (CEAS). Filtered
clusters that strand-specifically intersect RefSeq 3’UTR plus 1 kb additional
downstream genomic sequence (3’UTR) were used for 6mer analysis and
genome-wide target site analysis .

6mer enrichment analysis
The abundance of all possible 6mer sequences was found using the perl script
countkmer.pl (by Marco Blanchette) in moderately filtered clusters that strand
specifically intersect 3’UTR regions. The same was done for all refSeq 3’UTR
genomic sequences for use as background (normalized to contain the same total
number of 6mers as detected in clusters). The z-score and chi-square p-value
were calculated for all 6mer sequences enriched in clusters over refSeq 3’UTR
genomic sequences. The z-score was calculated for each 6mer by subtracting the
abundance in refSeq (background) from the abundance in clusters and
subsequently dividing by the standard deviation of the background subtracted
abundance of all 6mers. The value of the z-score conveys how far away from the
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mean a given 6mer is in units of standard deviation of the entire collection of
6mers.

Genome-wide target site analysis:
Bowtie was used to map all sequences complementary to miR-128 6mer seed to
mouse genome mm9, allowing no mismatches. Intersection was done with the
moderately filtered clusters in 3’UTR, generating genome browser tracks with
predicted miRNA targeted sites. All genome browser tracks were converted into
tables listing all genes detected with their predicted miRNA targeted sites

RNA Preparation
Mice were anaesthesized under CO2 and the cortex, hippocampus and striatum
were rapidly dissected and frozen in liquid nitrogen until further processing.
RNA

extraction

from

TriZol/Chloroform

frozen

technique

samples

according

was
to

performed

manufacturer’s

using

the

instructions

(Invitrogen Corporation, Carlsbad, CA). After extraction, RNA was precipitated
overnight at -80C in isopropanol with 0.15M sodium acetate, washed once with
70% ethanol, air-dried and resuspended in RNase-free water.
differences

in

miR-128

expression

in

D1-MSNs

versus

To address
D2-MSNs,

immunoprepitation of tagged Ago2 protein from the striatum of Drd1-Cre;
Rosa26-Ago2-Flag (n=4) and Drd2-Cre; Rosa26-Ago2-Flag (n=4) mice was
followed by isolation of associated RNA as described above.
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Purification of mRNA for D1-TRAP-profiling
Drd1a-cre; miR128-2fl/fl mutants are crossed to mice carrying D1-MSN specific
expression of eGFP tagged ribosome protein L10 (135). Procedure for striatal
dissection and tissue processing for microarray analysis are as previously
detailed (135).

Gene Expression Analysis by microarray.
Trizol-Chloroform extracted total RNA was further purified using an RNeasy
Micro Kit (Qiagen, Valencia, CA) with in-column DNase digestion, and analysed
using Nanodrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE)
and a Bioanalyzer (Agilent Technologies, Santa Clara, CA) to assess RNA
quantity and quality. Purified RNA was amplified and processed according to
the Affymetrix cDNA synthesis kit. Affymetrix Mouse Genome 430 2.0 arrays
were used in all experiments. Mouse Genome 430 2.0 arrays were scanned using
the GeneChip Scanner 3000 (Affymetrix, Santa Clara, CA) and globally scaled to
150 using the Affymetrix GeneChip operating software (GCOS v1.4). GeneChip
files (.cel) were imported into Genespring GX 11 (Agilent Technologies, Santa
Clara, CA) processed with GC-RMA algorithm and expression values on each
chip were normalized to median of all samples. Samples were compared to
similarly processed littermate control samples (n=4 each). All probes with
differential expression p-value<0.05, 2-way ANOVA (genotype) for TRAPprofiling were considered significantly changed in the absence of miR-128.
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Absolute Quantification of mature miR-128 in the brain
Quantitative RT-PCR was used to estimate copy number of miR-128 in brain
samples (Taqman, Life Technologies). Standard curve was generated using
synthetic single stranded RNA oligonucleotides of the mature miR-128 sequence
with 5’-phosphate and 3'-hydroxyl modification as synthetic miRNAs (IDT). RTPCR and quantitative real-time PCR were performed on duplicate serial
dilutions of the mimics according to manufacturer’s protocol and cycle count
was plotted against concentration of microRNA mimic. Mimic concentration was
converted to copies per cell using the assumption of ~15pg of total extracted
RNA per cell. All brain sample quantification used 15ng of total RNA input
(~1000 cells) and mean cycle count values from miR-128 quantification of wild
type striatum or cortex samples (n=16 and n=13 respectively) were used to
estimate copy number per cell in each sample type.

Taqman Quantitative RT-PCR for miRNA and mRNA analysis
Relative expression levels of mature miRNAs and mRNAs were measured by
Taqman assays using total extracted RNA from brain samples, according to
manufacturer’s protocol (Life Technologies, Carlsbad, CA). The purified RNA
samples were assayed by qRT-PCR for relative gene expression using predesigned Taqman gene expression assays from Applied Biosystems (ABI) as
recommended by the manufacture. The following pre-designed Taqman gene
expression assays from Applied Biosystems (ABI) were used: miR128 (Assay ID
002216), sno135 (Assay ID 001230), miR124a (Assay ID 001182). Cycle counts for
miRNA quantification were normalized to snoRNA135 unless otherwise
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indicated, cycle counts for mRNA quantification were normalized to GAPDH.
Relative expression (ΔCt) and quantification (RQ=2- C) for each mRNA were
ΔΔ

calculated using RQ Manager Software and the ΔΔCt method.

Luciferase Reporter Assay
Luciferase reporter assays were performed to measure repression of candidate
target 3’UTR by miR-128 mimics. MicroRNA 3’UTR target reporter plasmids
(Genecopoiea, MD) contained full length 3’UTR inserts cloned downstream of a
Firefly Luciferase gene. Control plasmids containing no inserts were used for
comparison. Reporter plasmids contained Renila Luciferase gene as reporter for
transfection efficiency. All plasmids were verified by sequencing and restriction
digests. Reporter or control plasmids were co-transfected into confluent
Neuro2A cells grown in 24-well culture plates with either no mimics, control
scrambled miR124 mimics or miR128 mimics at indicated concentrations
(Dharmacon, Thermo Fisher Scientific, USA). Cells were harvested and lysed 24
hour after transfection and cell lysate was assayed for Firefly luciferase and
Renilla Luciferase activity using Dual-Luciferase Reporter assay kit (Promega,
Wisconsin, USA) according to manufacturer’s instructions. Firefly Luciferase
activity was normalized to Renilla Luciferase activity for each culture well and
plotted as activity relative to control transfections with no mimics added. At least
3 biological replicates were performed consisting of 3 technical replicates each.
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Protein Quantification
Mice were anaesthesized under CO2 and the cortex, hippocampus and striatum
were rapidly dissected and frozen in liquid nitrogen until further processing.
Samples were sonicated on ice in 1% SDS solution supplemented with protease
inhibitor (Roche, Switzerland) and phosphatase inhibitor, and boiled for 10
minutes. Protein concentration was determined using BCA protein assay kit
(ThermoFisherScientific, USA) according to the manufacturer’s instructions.
Protein samples were diluted in equal volume of 2X loading buffer (Invitrogen)
and supplemented with DTT to a final concentration of 200mM (Sigma). 25ug of
protein samples were separated on 4-12% Bis-tris precast denaturing gels
(Invitrogen) and blotted onto PVDF membranes and blocked with 5% milk in
TBS- 0.1% Tween (TBST) solution for 1 hour at room temperature. Membranes
were probed with primary antibodies diluted in 5% milk-TBST solution
overnight at 4C.

Membranes were washed and probed with horseradish-

peroxidase conjugated anti-mouse or anti-rabbit IgG secondary antibody for 1
hour at room temperature. Membranes were developed using enhanced
chemiluminescence substrate (PerkinElmer, USA) and exposed on BioMax film
(Kodak, USA). Exposed films were scanned and protein bands quantified using
ImageJ Software (NIH, USA). Protein quantities were normalized using betaActin, phosphoprotein levels normalized to total non-phosphorylated protein
levels and all values plotted as relative to its control littermate sample. Primary
antibodies used: total ERK1/2 (137F5), phosphoERK1/2 (Thr202/Tyr204),
DARPP32 (19A3), phosphoDARPP32 (Thr34) (Cell Signaling, MA). RCS (mouse
monoclonal 6A, gift. A. Nairn), beta-Actin (Abcam), PEA15a (H80) (Santa Cruz),
D4ertd22e (Atlas),
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FACS analysis
Nuclei from mouse striatum were purified as previously described for cerebellar
mouse nuclei (189) including minor changes. Briefly, brains from decapitated
mice were frozen for 5 seconds in liquid nitrogen and the striata dissected on ice
and homogenized with a glass dounce homogenizer using first a loose then tight
pestle (Kimble Chase; 1984-10002). The cell homogenate was fixed with a final
concentration of 1% paraformaldehyde for 12 minutes at room temperature and
the reaction quenched with 0.125 M Glycine for 5 minutes at room temperature.
To isolate the striatal nuclei, the fixed homogenate was spun through a 29%
iodixanol cushion and the nuclei pellet resuspended in blocking buffer (0.25 M
sucrose, 25 mM KCl, 5 mM MgCl2, 20 mM Tricine pH 7.8, 1% Donkey Serum and
0.01% Tween-20) supplemented with 0.15 mM spermine, 0.5 mM spermidine,
EDTA‐free protease inhibitor cocktail (Roche; 11836170001) and phosphatase
inhibitor cocktail II (Calbiochem; 524625).

For FACS analysis, nuclei were

blocked overnight at 4ºC and stained for 1 hour at 4ºC using antibodies against
Histone H3 phosphorylation of Serine 10 (H3S10) conjugated to an Alexa555
fluorophore (Cell Signaling Technology; 3475S). FACS analysis was carried out
on a BD LSR instrument. Single nuclei were selected by gating on FSC and SSC
singlets. For the analysis of activated D1 nuclei, gating by two dimensional
criteria was used. First, the presence of a GFP signal above the background was
used to determine D1 nuclei from other striatal nuclei. Second, activated D1
nuclei were determined by a higher Alexa555 signal than Saline-injected D1
nuclei. Percentages of various nuclei populations were analyzed using Prism
software.
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Brain slice preparation
Para-sagittal brain slices (275 µm) were obtained from 3-5 month old male and
female wild type and mutant mice following procedures approved by the
Northwestern University Animal Care and Use Committee. The mice were
anesthetized with a mixture of ketamine (50 mg kg–1) and xylazine (4.5 mg kg–1)
and perfused transcardially with 5–10 ml ice-cold artificial cerebrospinal fluid
(ACSF) containing (in mM): 124 NaCl, 3 KCl, 1 CaCl2, 1.5 MgCl2, 26 NaHCO3, 1
NaH2PO4, and 16.66 glucose, continuously bubbled with carbogen (95% O2 and
5% CO2). The slices were then transferred to a holding chamber where they were
incubated in ACSF containing (in mM) 2 CaCl2, 1 MgCl2, at 35ºC for 60 min, after
which they were stored at room temperature until recording.

Electrophysiology
Patch pipettes were pulled from thick-walled borosilicate glass on a Sutter P-97
puller. Pipette resistance was typically 3–5 MΩ when filled with recording
solution. For studies involving bAP propagation the internal recording solution
contained (in mM): 135 KMeSO4, 5 KCl, 10 HEPES, 2 ATP-Mg2+, 0.5 GTP-Na+, 5
phosphocreatine-tris; 5 phosphocreatine-Na+, 0.1 spermine; pH was adjusted to
7.25 with NaOH and osmolarity to 270–280 mOsm l–1.

For Ca2+ imaging

experiments,

200

the

recording

solution

also

contained

µM

Fluo-4

pentapotassium salt and 50 µM Alexa Fluor 568 hydrazide Na+ salt (Invitrogen).
For voltage clamp studies the recording solution contained (in mM): 120
CsMeSO3, 5 NaCl, 10 TEA-Cl (tetraethylammonium-Cl), 10 HEPES, 5 Qx-314, 4
ATP-Mg2, 0.3 GTP-Na, 0.2 Fluo 4 pentapotassium salt and 0.05 Alexa Fluor 568
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hydrazide Na+ salt (Invitrogen), pH 7.25, 270-280 mOsm-1.

Slices were

transferred to a submersion-style recording chamber mounted on an Olympus
BX51 upright, fixed-stage microscope and continuously perfused with carbogenbubbled ACSF. Electrophysiological recordings were obtained with a Multiclamp
700B amplifier. Stimulation and display were obtained as previously described
(128) using the custom-written shareware package WinFluor (John Dempster,
Strathclyde University, Glasgow, Scotland, UK), which automates and
synchronizes the two-photon imaging and electrophysiological protocols. The
amplifier bridge circuit was adjusted to compensate for serial resistance and
continuously monitored during recordings. Analysis of mEPSCs was performed
in the presence of 1 µM TTX using MiniAnalysis software (Synaptosoft).

2-photon laser scanning microscopy (2PLSM) and Ca2+ imaging
2PLSM and Ca2+ imaging were performed as previously described (128).
Striatonigral SPNs were identified by somatic eGFP two-photon excited
fluorescence using an Ultima Laser Scanning Microscope system (Prairie
Technologies). A DODT contrast detector system was used to provide a brightfield transmission image in registration with the fluorescent images. The green
GFP signals (490–560 nm) were acquired using 810 nm excitation (Verdi/Mira
laser). SPNs were patched using video microscopy with a Hitachi CCD camera
and an Olympus 60X/0.9 NA lens.

Alexa 568 fluorescence was used for

visualization of cell bodies, dendrites, and spines. Following patch rupture, the
internal solution was allowed to equilibrate for 15–20 minutes before imaging.
Whole cell maximum projection images of the soma and dendrites were acquired
with 0.36 µm2 pixels with 10 µs pixel dwell time; ~80 images taken with 1 µm
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focal steps. High magnification maximum projection images of dendrites were
acquired with 0.072 µm2 pixels with 10 µm pixel dwell time; ~20 images taken
with 0.5 µm focal steps.

Spine density was calculated from maximum projection images of dendritic
segments ~100-120 µm from the soma, as previously described (Chan et al.,
2012).

Spines were manually counted and normalized to the length of the

corresponding dendrite.

Single bAPs were generated by injecting somatic current pulses (2 nA, 2 ms).
Dendritic changes in Ca2+ were measured as ∆F/Fo via line scans, where Fo is the
average green fluorescence before the bAP.

Peak ∆F/Fo values were obtained

from the average of 6 consecutive trials and calculated by a single exponential fit
of the Ca2+ transient decay. Green fluorescent line scan signals were acquired at
6 ms per line and 512 pixels per line with 0.08 µm pixels and 10 µs pixel dwell
time. The laser-scanned images were acquired with 810 nm light pulsed at 90
MHz (~250 fs pulse duration). Power attenuation was achieved with two Pockels
cells electro-optic modulators (models 350–80 and 350–50, Con Optics, Danbury,
CT). The two cells were aligned in series to provide an enhanced modulation
range for fine control of the excitation dose (0.1% steps over four decades). The
line scan was started 200 ms before the stimulation protocol and continued 4 s
after the stimulation to obtain the background fluorescence and to record the
decay of the optical signal after stimulation. To reduce photo-damage and photobleaching, the laser was fully attenuated using the second Pockels cell at all times
during the scan except for the period directly flanking the bAP burst.
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Dendritic line scans were acquired from proximal (~50 µm from soma) and distal
(~100-120 µm from soma) dendritic regions for each cell. bAP attenuation was
calculated by normalizing distal Ca2+ transient peaks to the maximum proximal
Ca2+ transient per cell.

Drugs
Mice were injected intraperitoneally with volume of 10X body weight.
D1-receptor agonist SKF81297 (Taconic) is diluted from stock (10mg/ml in
DMSO) with 0.9% saline to indicated concentration. MEK inhibitor SL327
(Taconic) is diluted from stock (diluted in DMSO) with 30% DMSO/Saline to
indicated concentration.

Behavior Analyses
All behavior tests have been performed on 4- to 16-week-old mutants and their
respective age and sex-matched littermate controls. All behavior tests were
conducted between 7 AM and 7 PM.

Open-Field Analysis
Locomotion and exploratory behavior was measured using the open field
analysis in novel environment (clear plexiglass chamber 40 X 40 X 30 cm ).
Activity was quantified by computer-operated Photobeam activity system
(Accuscan Instruments, Columbia, OH). Mice were recorded for total distance
moved in the whole arena, distance moved in center vs periphery of arena
(thigmotaxis) and number of vertical episodes (rearing). Data was collected in 5
or 10 min intervals over 60-100 min test sessions.
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Home Cage Seizure Monitoring
Animals were housed in clear plexiglass chambers with pre-installed cameras
(Phenotyper, Noldus Information Technology), and provided with food and
water ad libitum. Continuous 24-hour video recordings of mice were taken.
Video recordings were manually scored for severity, duration and frequency of
seizures. To constitute a recorded tonic-clonic seizures, mice must cease all
normal activity such as walking, sniffing or grooming, adopt a rigid posture with
arched back and progress to repeated rearing and falling. A large majority of
tonic clonic seizure episodes progressed to a further stage with rapid running
and bouncing behavior, although this was not required for inclusion as tonicclonic seizure.

Chemically-induced seizures.
Mice were injected i.p. with kainic acid (30 mg/kg in saline) or picrotoxin (3
mg/kg in saline) and placed in chambers in isolation and observed for 60 min.
All injected animals rapidly enter period of immobility (Stage 1). Animals were
observed for the time of onset of tonic clonic seizures characterized by repeated
rearing and falling followed by running and bouncing or constant limb
movements if postural control is lost.

Survival Analysis
Date of sacrifice or death in the home cage is recorded for mutants and cage mate
controls, and plotted as Kaplan-Meier survival curves and compared using logrank tests.

138

6-OHDA lesion
Mice were anaesthesized with ketamine/xylazine. Stereotactic injection of 6OHDA (3.5mg/ml in 0.02% ascorbic acid) 2X2ul in left striatum (ML=-2.1
AP=+1.0 DV=-3.4; ML=-2.3 AP=+0.3 DV=-3.4). and vehicle injection 2X2ul in
right striatum (ML=+2.1 AP=+1.0 DV=-3.4; ML=+2.3 AP=+0.3 DV=-3.4). Mice
were single housed for 3 weeks after surgery to allow for recovery before
behavioral assays.

Rotational behavior
Rotational behavior in lesioned mice was assayed by an experimenter blind to
the genotypes for 2X2min interval 5 min after injection of cocaine (10 mg/kg).
Net contralateral rotations are average of 4 readings taken over 2 days. After 3
days, the same behavior was recorded in response to D1-agonist SKF81297 (5
mg/kg).

Cocaine-conditioned place preference
Mice were exposed to the 3-chamber experimental set-up (Med Associates) for
15 minutes, a day before the first test to allow mice to acclimatize to testing
conditions. During testing phases, mice were placed in the center chamer and
allowed free access to all chambers. Chamber entries and duration spent in each
chamber was measured by the automated system. During daily conditioning,
two pairings were performed. In the first pairing, mice were injected with either
saline or cocaine (15mg/kg) and allowed to explore a pre-selected pairing
chamber (left or right) for 15 minutes. 4 hours later, the second pairing is
performed in which mice were injected with the other solution and placed in the
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other chamber for 15 minutes. The duration of the time spent in each chamber
during the test phases were recorded.

Novel object recognition task
Test was performed in a clear plexiglass chamber. Mice were allowed exposed to
the empty chamber one day before tests to allow mice to acclimatize. During the
training phase, the mice were first allowed to explore the empty chamber for 5
minutes.Then the mice are removed and 2 identical training objects were placed
in opposite sides of the chamber before the mice were re-introduced into the
chamber. Time spent in exploration of each object was manually assessed by an
experimenter blinded to the genotypes of the mice. Exploration behavior was
characterized by sniffing directed at the object or forelimb contact with the
object. Mice were removed into a new cage for 1 hour until the first test phase.
One training object and one novel object was placed in the same positions and
mice was re-introduced and exploratory behavior was assessed as before. Object
placements were randomized for each mouse to preclude position-dependent
effects. Second test phase was performed 24 hour after the training phase using a
new "novel" object and one training object.

Statistical analysis
Analyses were performed using either Microsoft Excel or Graphpad Prism
software.
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